日本癌治療学会誌 = The journal of Japan Society of Clinical Oncology  19(2)

日本癌治療学会 [編]

[目次]

• Presidential Lecture Progress in Chemotherapy for Advanced Cancer--From Leukemia to Solid Tumor / K.Kimura / p163～163
• Special Lecture 1.Cancer Immunology:Monoclonal Antibodies, Vaccines and Tumor Necrosis Factor / L.J.Old / p164～165
• Special Lecture 2.Strategies for the Chemotherapy of Solid Tumors / J.R.Bertino / p166～166
• Special Lecture 3.Recent Advance in the Diagnosis of Esophageal and Colo-rectal Cancer / H.Shirakabe / p167～167
• Symposium 1 New Tumor Marker / / p168～176
• 1.Structural Change of the Sugar Chains of Glycoproteins by Cell Transformation and Its Application to the Diagnosis of Cancer / A.Kobata / p168～168
• 2.Serological Typing with Monoclonal Antibodies for Classification of Hematopoietic Tumors / R.Ueda et al. / p169～169
• 3.Human Gastrointestinal Tumor Markers Defined by Monoclonal Antibodies / K.Imai et al. / p170～170
• 4.A Monoclonal Antibody Reactive with Gastric Carcinoma / T.Sekine / p171～171
• 5.Immunodiagnosis of Gastric, Colorectal and Pancreatic Carcinoma with a Monoclonal Antibody against the Gastrointestinal Tumor-associated Antigen CA 19-9 / M.Herlyn / p172～172
• 6.Pancreatic Oncofetal Antigen(POA) and Carcinoma of the Pancreas / T.Homma / p173～173
• 7.Novel γ-Glutamyl Transpeptidase Isoenzyme and Hepatocellular Carcinoma / N.Sawabu et al. / p174～174
• 8.Evaluation of Neuron-specific Enolase as a New Tumor Marker for Carcinoma of the Lung / Y.Ariyoshi / p175～175
• 9.Tumor-antigen TA-4 of Squamous Cell Carcinoma in Patients with Cervical Cancer / H.Kato / p176～176
• Symposium 2 Enhancement of Effects of Cancer Chemotherapy--New Trials and Results / / p177～183
• 1.Chemical Modification of Anticancer Agents in the Viewpoints of Their Pharmacokinetics / H.Fujita / p177～177
• 2.Clinical Studies on Induced Hypertension Chemotherapy Based on the Functional Characteristics of Microcirculation of Tumor Vessels / A.Wakui et al. / p178～178
• 3.Reversal of Acquired Resistance to Vinca Alkaloids and Anthracycline Antibiotics by Calcium Channel Blockers and Calmodulin Inhibitors / T.Tsuruo / p179～179
• 4.Regulation of Enzyme Activities Involved in Pyrimidine Synthesis and Its Application Cancer Chemotherapy / T.Shirasaka et al. / p180～180
• 4'.UFT and UFTM Treatment for Gastric Cancer / S.Suga / p181～181
• 5.Synergistic Antitumor Effect of Poly(ADP-Ribose) Synthesis Inhibitor and DNA-Damaging Agent / M.Fukushima et al. / p182～182
• 6.Effect of Intra-aortic PGE Infusion in Patients with Neuroblastoma--Differentiation Induction and Potentiation of Chemotherapy / S.Imashuku / p183～183
• Symposium 3 Problems and Course for the Future in Mass Screening for Cancer / / p184～188
• 1.Present Problems and Future Progress of Gastric Mass Survey in Japan / S.Hisamichi / p184～184
• 2.Not Received / /
• 3.Future Countermeasures for Early Detection of Lung Cancer / T.Naruke / p185～185
• 4.The Problems and the Course for the Future in the Mass Screening for the Cancer--Glandula Mammaria / H.Watanabe / p186～186
• 5.Problems in Mass Screening Program for Prostatic Diseases / H.Watanabe / p187～187
• 6.Mass Screening for Colorectal Cancer / S.Kobayashi / p188～188
• Symposium 4 Problems in Treatment of Early Cancer / / p189～198
• 1.Problems in Treating Early Cases of Head and Neck Cancer / M.Hirano / p189～189
• 2.Controversy on Treatment of Early Breast Cancer / K.Enomoto et al. / p190～190
• 2'.Some Problems in the Treatment of Early Breast Cancer / M.Izuo / p191～191
• 3.Present and Future Problems in the Treatment of Early Lung Cancers / K.Suemasu et al. / p192～192
• 4.Controversy for Treatment of Early Esophageal Cancer / M.Endo / p193～193
• 5.The Problem and the Present Status of Surgical Treatment for Early Gastric Cancer / M.Nishi et al. / p194～194
• 6.Problems on Treatment of Early Cancer--Pancreatic Cancer / K.Takagi / p195～195
• 7.Treatment of Early Cancer--Large Bowel Cancer / K.Kato / p196～196
• 8.Problems in the Treatment of Early Stage Urogenital Cancer / K.Koiso et al. / p197～197
• 9.Problem on Treatment for Early Carcinoma of the Uterine Cervix / T.Yamabe / p198～198
• Symposium 5 Function Preservation in Cancer Therapy / / p199～204
• 1.Treatment of Maxillary Cancer--Strategy to Avoid Post-operative Cosmetic and Functional Disabilities / M.Morita / p199～199
• 2.Breast Cancer / K.Kuno / p200～200
• 3.Radical Operation for Rectal Cancer to Preserve Anorectal,Urinary and Sexual Function / S.Kodaira et al. / p201～201
• 4.The Problems on the Preservation Treatment of the Vesical Function for the Bladder / K.Matsumoto / p202～202
• 5.Functional Saving in the Treatment of Cervical Cancer / K.Sekiba / p203～203
• 6.Malignant Bone Tumors / I.Maeyama / p204～204
• Symposium 6 Multidisciplinary Treatment for Undifferentiated Carcinoma--Scirrhous Carcinoma in the Stomach and Small Cell Carcinoma in the Lung / / p205～214
• 1.Scirrhous Cancer of the Stomach Its Pathology and Histogenesis / I.Kino / p205～205
• 2.Biological Characteristics of Small-Cell Carcinoma of the Lung / T.Kameya / p2O6～2O6
• 3.The Chemotherapy of Unresectable Borrmann Type 4 Gastric Cancer / M.Kurihara et al. / p207～207
• 4.Surgical Treatment of Borrmann 4-type(Diffuse) Gastric Cancer / M.Hirono / p208～208
• 4'.Treatment Methods Based on Extensions of Macroscopical Subtypes in Type Borrmann-4 of Gastric Carcinoma / T.Iwanaga / p209～209
• 5.Small Cell Carcinoma of the Lung--From the Surgical Point of View / K.Oho / p210～210
• 6.Combination Chemotherapy with a Multimodality Approach for Small Cell Lung Cancer / T.Ohnoshi / p211～211
• 6.'Correlation between the Therapeutic Response and the Type of Development of Small Cell Lung Cancer / Akira Suzuki / p212～212
• 4''.The Result of Chemo-endocrine Therapy for Female Patients with Diffuse Carcinoma of the Stomach / H.Kitaoka / p213～213
• 4'''.Proliferation of Scirrhous Type of Gastric Carcinoma and Its Treatment / H.Kamei / p214～214
• Symposium 7 Characteristics and Treatment of Metastases to Central Nervous System / / p215～222
• 1.Characteristics and Treatment of CNS Metastases in Lung Cancer / H.Ikegami / p215～215
• 2.Characteristics and Treatments of the Patients with Central Nervous System Metastases of Breast Cancer / T.Tominaga / p216～216
• 3.Acute Leukemia / T.Fujimoto / p217～217
• 4.Cerebral Metastasis of Choriocarcinoma / S.Kaseki et al. / p218～218
• 5.Surgical Treatment of Brain Metastases / J.Yamashita / p219～219
• 6.Radiation Therapy of Brain Metastases / K.Hata / p220～220
• 7.Multidisciplinary Treatment of Metastatic Brain Tumor and Its Fundamental Studies for Chemo-immunotherapy / T.Kobayashi / p221～221
• 8.Nuclear Magnetic Resonance Imaging of Metastatic Brain Tumors / T.Araki / p222～222
• Symposium 8 Cancer Surgery--Concerning Extension of Operation / / p223～234
• 1.The Advantage and Limit of Surgical Therapy to Esophageal Cancer / S.Abo et al. / p223～223
• 2.Extent of Lymphnode Dissection and Prognosis / K.Isono / p224～224
• 3.Surgical Treatment of Carcinoma of the Stomach Invading to Gastro-Esophageal Junction / K.Sasaki et al. / p225～225
• 4.Carcinoma of the Upper Portion of the Stomach:Total Gastrectomy or Proximal Partial Gastrectomy? / N.Kaibara et al. / p226～226
• 5.Critical Evaluation of Prophylactic Splenectomy in Total Gastrectomy for the Stomach Cancer / K.Sugimachi et al. / p227～227
• 6.Radical Surgery for Advanced Bowel Cancer with Involvement to Adjacent Viscera or Distant Metastasis--Coincidental Resection of the Involved Organ / K.Hojo / p228～228
• 7.Large Intestinal Cancer Surgery,Effective Excisional Area on the Stand-point of Lymphnode Dissection / T.Takahashi / p229～229
• 8.Boundaries for Resection and Lymph Node Dissection in Terms of Preservation of Postoperative Functions and Radicality of the Cancer of the Colon and Rectum / M.Yasutomi / p230～230
• 9.Indication of Extended Hepatectomy for Liver Cancer / T.Noguchi / p231～231
• 10.Indication of Minimized Regional Operation for Primary Liver Cancer / Y.Nakanishi et al. / p232～232
• 11.Extended Type of Pancreatectomy and Physiological Reconstruction for Cancer of the Pancreas / T.Suzuki et al. / p233～233
• 12.Carcinoma of the Pancreas-Mode of Spread and Magnitude of Surgical Management / H.Yamauchi et al. / p234～234
• Symposium 9 Evaluation of Sensitivity for Anti-cancer Agents Correlated with Clinical Effectiveness / / p235～245
• 1.Clinical Evaluation on the Sensitivity Test for Anti-cancer Agents in Malignant Bone and Soft-tissue Tumors / S.Takeuchi et al. / p235～235
• 2.In vitro Chemosensitivity Test of Human Solid Cancers
• ³H-thymidine Uptake Inhibition Test / Y.Hanatani et al. / p236～236
• 3.Application of Radioactive Precursors for the Evaluation of Sensitivity of Cancer Cells to Anticancer Drugs / H.Ichihashi et al. / p237～237
• 4.Anticancer Drug Sensitivity Tested by the Tumor Stem Cell Assay / S.Hiraki / p238～238
• 5.Chemosensitivity Testing for Human Ovarian Cancer on in vitro Colony Assay / K.Inoue / p239～239
• 6.Predictive Drug Testing by Clonogenic Assay--Tumor Heterogeneity as Regards Drug Sensitivities / N.Tanigawa et al. / p240～240
• 7.Establishment of Human Tumor Cell Lines in Nude Mice in Ascitic Form and Application to the Screening System of Antitumor Agents / T.Kitahara / p241～241
• 8.Experimental Chemotherapy of Human Gastrointestinal and Breast Cancer Xenografts in Nude Mice with Drugs in Clinical Use and under Development,with Special Reference to Their Predictability to Clinical Effects / M.Fujita et al. / p242～242
• 9.Anti-cancer Drug Sensitivity Test against Xeno-grafts of Malignant Human Lung Tumor / M.Kitano / p243～243
• 10.Sensitivity Test of Anticancer Agents Using Human Tumor Xenografts in Nude Mice with Special Reference on Correlation between Clinical Effects and Chemotherapy / Y.Nosoh et al. / p244～244
• 11.Histological Evaluation of Cancer Chemotherapy on Rat Ovarian Cancer--A Comparison with Human Case / T.Nishida / p245～245
• Symposium 10 Countermeasure to Side Effects of Cancer Chemotherapy and Radiotherapy / / p246～251
• 1.Myelotoxicity due to Cancer Chemotherapy--Autologous Bone Marrow Transplantation for the Treatment of Malignant Tumors / S.Nakamura / p246～246
• 2.Gastrointestinal Disturbance by Cancer Chemotherapy--Recent Progress in Antiemetic Regimens / M.Murakami / p247～247
• 3.Chronic Cardiotoxicity of Anthracycline Derivatives and Possible Prevention by CoenzymeQ¹⁰ / M.Tashima et al. / p248～248
• 4.Interstitial Pneumonitis-fibrosis Induced by the Administration of Cytotoxic Agents / K.Oizumi / p249～249
• 5.Pulmonary Side Effects of Radiation Therapy / Y.Imajo / p250～250
• 6.Radiation Induced Late Effect of Central Nervous System / M.Kakehi / p251～251
• Panel Discussion 1 Efficacy and Problems of Cancer Immunotherapy / / p252～255
• 1.A Controlled Study of Surgical Adjuvant Chemoimmunotherapy for Advanced Gastric Cancer--The Third Study of Tokai Cooperative Study Group for Adjuvant Chemoimmunotherapy of Stomach Cancer / M.Yasue et al. / p252～252
• 2.Adjuvant Immunotherapy of Gastric Cancer / R.Hayashi et al. / p252～252
• 3.Prognostic Factor Analysis of Postoperative Adjuvant Immunotherapy in Gastric Carcinoma / Y.Miyamoto et al. / p252～252
• 4.Evaluation and Improvement of Immunotherapy in Cancer Patients / T.Toge et al. / p253～253
• 5.Factors Enhancing the Efficacy of Immunotherapy for Gastric Cancer / H.Miwa et al. / p253～253
• 6.Sequential Combination Chemoimmunotherapy for Advanced Carcinoma / S.Arinaga et al. / p253～253
• 7.Effect of Intrapleural Instillation of N-CWS against Lung Cancer as an Adjuvant Immunotherapy / K.Yasumoto et al. / p254～254
• 8.Effects of Specific Active Immunotherapy on Acute Lymphoblastic Leukemia in Children / H.Yamamoto et al. / p254～254
• 9.Immunological Function and the Effect of Immunotherapy in Protein--Deficient Mice / M.Akimoto et al. / p254～254
• 10.Analysis of Immunosuppressive Mechanism in Anti-cancer Immunity and Immunoaugmentation by Newly Established Biological Response Modifiers / Y.Kohgo et al. / p255～255
• Panel Discussion 2 Double Cancer and Second Cancer Following Cancer Therapy / / p256～258
• 1.Neoplasma Following Therapeutic Irradiation for Malignant Conditions in Head and Neck Lesion / K.Ichikawa et al. / p256～256
• 2.The Double Cancer in Alimentary Tract / T.Mori et al. / p256～256
• 3.Clinical Significance of Second Primary Cancers in the Large Intestine and Stomach / I.Fukuda et al. / p256～256
• 4.Multiple Primary Neoplasms: One of Which was Lung Cancer / R.Tsuchiya et al. / p257～257
• 5.Primary Malignant Tumors among Breast Cancer Patients / F.Kasumi et al. / p257～257
• 6.Double Primary Malignancies after the Treatment of Breast Cancer / S.Miura et al. / p257～257
• 7.Second Primary Malignant Tumors Following Therapy for Carcinoma of the Uterine Cervix / T.Hamada et al. / p258～258
• 8.Double Cancer Observed from Occupational and Environmental Bladder Cancer / M.Matsushima et al. / p258～258
• Panel Discussion 3 Long-term Survivals in Cancer Chemotherapy / / p259～263
• 1.Studies on Long-Term Survivors with Advanced Gastrointestinal Cancer / H.Takahashi et al. / p259～259
• 2.Long-term Survival of the Patients with Gastrointestinal Cancer Received Anti-cancer Chemotherapy / Y.Sasaki et al. / p259～259
• 3.Long Time Survivals in Cancer Chemotherapy / I.Nakao et al. / p259～259
• 4.Long Term Survivals after Absolutely Non-curative Resection of the Stomach Cancer / O.Takeuchi et al. / p260～260
• 5.Long Survival Patients with Hepatocellular Carcinoma Treated with Arterial Infusion of Anticancer Agents / T.Tsuburaya et al. / p260～260
• 6.Long Survivors of Non Small Cell Lung Cancer Patients with Cancer Chemotherapy / M.Yamamoto et al. / p260～260
• 7.Clinical Study of Prognostic Factors of Metastatic Breast Cancer Patients / M.Kitamura et al. / p261～261
• 8.The Study on the Long Term Survived Patients with Brain Tumors Treated with ACNU and PSK after Surgery / Y.Saito et al. / p261～261
• 9.Two Cases of Uterine Cervical Cancer Living Well over 10 Years after Chemotherapy for the Recurrence / T.Kasamatsu et al. / p261～261
• 10.Clinical Evaluation of Chemoimmunotherapy for Uterine Cervical Cancer / H.Taniguchi et al. / p262～262
• 11.Long Term Examination of the Patients with Oral Squamous Cell Carcinoma Which Disappeared Clinically by Bleomycin Therapy / T.Amagasa et al. / p262～262
• 12.Long-term Follow-up of Patients with Malignant Lymphoma Treated with Combination Chemotherapy / R.Nishihara et al. / p262～262
• 13.Long-term Survivors of Acute Leukemia in Japan / K.Kawashima et al. / p263～263
• Panel Discussion 4 Hyperthermia / / p264～266
• 1.A Study the Combined Effect of Radiation and Hyperthermia / Y.Kawada et al. / p264～264
• 2.The Development of Electromagnetic Wave Applicators for Intraluminal Hyperthermia:Experimental and Clinical Results / H.Kai et al. / p264～264
• 3.Hyperthermic Therapy on Urogenital Malignancies: Application of Shortwave Radiofrequency(RF) / Y.Kubota et al. / p264～264
• 4.Regional Hyperthermia in the Treatment of Locally Advanced Deepseated Malignancy / S.Yanagawa et al. / p265～265
• 5.Clinical Significance of Hyperthermia Combined with Radiotherapy / T.Matsuda et al. / p265～265
• 6.Clinical Results of Radiothermotherapy in the Treatment of Refractory Cancers / M.Hiraoka et al. / p265～265
• 7.Hyperthermochemotherapy for Unresectable Pancreatic Cancer / Y.Yamamoto et al. / p266～266
• 8.Continuous Hyperthermic Peritoneal Perfusion with Large Dose of Mitomycin C in the Treatment and the Prophylaxis of Peritoneal Metastasis in Gastric Cancer Surgery / R.Hamazoe et al. / p266～266
• 9.Clinical Result of S-HT in Combination with Chemotherapy and Radiotherapy / M.Hosoi et al. / p266～266
• Panel Discussion 5 New Approach in Cytological Diagnosis / / p267～270
• 1.The Application of Immunoperoxidase Technique to Cytology-Detection of CEA by Immunoelectron Microscopic Studies / H.Hata et al. / p267～267
• 2.Immunohistological Approach to the Clinical Cytology by Detection of Cancer Markers Using Immunoperoxidase Technique / K.Nishida et al. / p267～267
• 3.study of Cancer Cell Kinetics by means of Quantitative Cytochemistry / C.Konaka et al. / p267～267
• 4.Application of Flow Cytometry to the Gynecological Cytology / T.Kagabu et al. / p268～268
• 5.Application of Fine Nozzle Jet Method for the Preparation of Specimens Suitable to High Resolution Cell Image Analysis / M.Danno et al. / p268～268
• 6.Percutaneous Transabdominal Fine Needle Aspiration Cytology of Regional Lymph Nodes of Genitourinary Cancer / S.Hoshi et al. / p268～268
• 7.Diagnostic Significance of Bile Cytology in Obstructive Jaundice / Y.Iitsuka et al. / p269～269
• 8.Cytology of Bladder Carcinoma by Chromosome Analysis / T.Nagayama / p269～269
• 9.Cytological Diagnosis of Carcinoma of the Prostate: An Use of Specially Designed Prostatic Fluid Obtaining Catheter / S.Ichijo et al. / p269～269
• 10.Scanning Electron Microscopy on Human Urinary Cytology / H.Kumon et al. / p270～270
• 11.Mass Screening for Urinary Tract Cancer with Urine Cytology / T.Shioya et al. / p270～270
• 12.Prospects of Application of Monoclonal Antibodies for Diagnostic Cytology With Special Reference to Cytological Diagnosis of Leukemia and Malignant Lymphoma / K.Kikuchi et al. / p270～270
• Panel Discussion 6 Ways of Maintenance Chemotherapy for Cancer / / p271～273
• 1.Evaluation of 5000 Leukocyte Differential for Remission Maintenance Chemotherapy and Early Diagnosis of Relapse in Acute Leukemia / H.Shibata et al. / p271～271
• 2.Adjuvant Chemotherapy after Surgery of Advanced Gastric Cancer / S.Hirose et al. / p271～271
• 3.Evaluation of Postoperative Adjuvant Chemotherapy with FT-207 for Gastric Cancer / T.Tanaka et al. / p271～271
• 4.Not Received / /
• 5.The Role of Prolonged Surgical Adjuvant Chemotherapy in Cancer of the Colon and Rectum / T.Kato et al. / p272～272
• 6.The Value of Maintenance Therapy in Disseminated Testicular Cancer / T.Miki et al. / p272～272
• 7.Maintenance Chemotherapy with L-PAM for Ovarian Cancer after Combined Modality with CAPF and Second-Look Operation / J.Inagaki et al. / p272～272
• 8.Study on the Effect of Classification and Adjuvant Chemotherapy for Cervical Carcinoma / T.Maeda et al. / p273～273
• 9.The Role of Maintenance Chemotherapies with Malignant Brain Tumors / H.Yamamoto et al. / p273～273
• Panel Discussion 7 Spontaneous Regression of Cancer / / p274～275
• 1.A Case of Complete Remission of Carcinomatous Peritonitis / T.Yamada et al. / p274～274
• 2.A Case of Spontaneous Regression of Pulmonary Metastases of Renal Cell Carcinoma / M.Tsuruta et al. / p274～274
• 3.Spontaneous Regression in Neuroblastoma / J.Uchino et al. / p274～274
• 4.Pathohistological and Immunological Research of Spontaneous Regression or Long Survival Cancer Cases (IX) -On Local Lymphocyte Infiltration and Immunological Alteration of Long Survival Cases of Cancer Patients / S.Nakagawa et al. / p275～275
• Panel Discussion 8 Role of Radiotherapy in Multidisciplinary Treatment for Cancer / / p276～281
• 1.The Role of Radiotherapy for Malignant Brain Tumors in Multidisciplinary Therapy / H.Yamamoto et al. / p276～276
• 2.Combined Modality Treatment with Radiation Therapy and Chemotherapy in Localized Cancer in the Head and Neck / N.Masaki et al. / p276～276
• 3.Availability of Combination Therapy Using Operation with Irradiation in the Esophageal Cancer / M.Ikeda et al. / p276～276
• 4.Significance of Radiation Therapy in Multidisciplinary Treatment for Esophageal Cancer / K.Morita et al. / p277～277
• 5.Radiotherapy for Carcinoma of the Lung / Y.Takegawa et al. / p277～277
• 6.Postoperative Radiation Therapy for Carcinoma of the Gallbladder and Biliary Tract / Y.Ogura et al. / p277～277
• 7.The Role of Fast Neutron Radiotherapy in the Multi-modal Treatment of Osteosarcoma / N.Takada et al. / p278～278
• 8.The Role of Radiotherapy on the Management of the Malignant Lymphoma / H.Niibe et al. / p278～278
• 8'.Contribution of the Radiotherapy in the Treatment for Breast Cancer / T.Okawa et al. / p278～278
• 8''.The Role of Radiotherapy in Multimodal Treatment for Breast Cancer / Y.Nakada et al. / p279～279
• 8'''.Role of Radiotherapy in Multidisciplinary Treatment for Esophageal Carcinoma / S.Onoda et al. / p279～279
• 8''''.Radiotherapy in the Multidisciplinary Treatment for Esophageal Carcinoma / T.Iizuka / p279～279
• 9.The Role of Radiotherapy in the Treatment of Ovarian Cancer / J.Umezu et al. / p280～280
• 9'.The Role of Radiotherapy in the Combination Treatment for Carcinoma of the Uterine Cervix / T.Arai et al. / p280～280
• 9''.The Role of Radiation Therapy in the Treatment for Nonseminomatous Germinal Tumors of the Testis / M.Miki et al. / p280～280
• 9'''.Evaluation of Radiation Therapy for Small Cell Lung Cancer in Randomized Study / R.Arai et al. / p281～281
• Panel Discussion 9 Laser Therapy for Cancer / / p282～284
• 1.CO₂ Laser Therapy of Intraepithelial Neoplasias of Cervix,Vulva,and Vagina / N.Tsukamoto et al. / p282～282
• 2.Laser Surgery and FAR for Advanced Cancer of the Mesopharynx / T.Yoshida et al. / p282～282
• 3.Transendoscopic Nd-YAG Laser Treatment of Lung Cancer / K.Oho et al. / p282～282
• 4.Transurethal Laser Surgery for Bladder Tumor / K.Okada et al. / p283～283
• 5.Endoscopic Laser Treatment for Tumors of the Gastrointestinal Tract / H.Sugiura et al. / p283～283
• 6.Endoscopic Laser Treatment of Gastrointestinal Cancer / M.Maruyama et al. / p283～283
• 7.Experimental and Clinical Studies of HPD Photoradiaton Therapy for Upper Gastrointestinal Cancer / S.Mimura et al. / p284～284
• 8.Photoradiation Therapy of Superficial Bladder Tumors and CIS / H. Hisazumi et al. / p284～284
• 9.Photodynamic Therapy for Malignant Tumors, Especially Lung Cancer, with Hematoporphyrin Derivative and Laser Beam / H. Kato et al. / p284～284
• Panel Discussion 10 Intraarterial Infusion Chemotherapy / / p285～290
• 1.Intraarterial Infusion Therapy of the Stage III Breast Cancer / T.Ueda et al. / p285～285
• 2.Characteristics and Limitation of Intra-arterial lnfusion Cancer Chemotherapy with Special Reference to Intra-aortic Infusion / K.Yoshikawa et al. / p285～285
• 3.Constant Intra-arterial Infusion Chemotherapy for Cancer Patients with Peritoneal Metastases / M.Sato et al. / p285～285
• 4.Technical Improvement in Transcatheter Intraarterial Chemotherapy / K.Hiramatsu et al. / p286～286
• 5.Intra-arterial Infusion Chemotherapy Using an Implantable Pump for the Treatment of Cancers of Liver and Pancreas / T.Miura et al. / p286～286
• 5'.Low Dose-intermittent Intraarterial Infusion Chemotherapy of MFC Using a Sub-cutaneously Implanted Silicone Reservoir / Y. Arai et al. / p286～286
• 5''.Infusion Anti-cancer Chemotherapy through a Directly Wedged Arterial Catheter / M.Takahashi et al. / p287～287
• 6.Hemodynamic Study during Intra-arterial Infusion Chemotherapy of Hepatic Cancer--Examination by Kr-81m,Xe-133,Tc-99m-MAA via the Hepatic Artery / Y.Sasaki et al. / p287～287
• 7.Arterial Infusion Chemotherapy with Angiotensin 2 for Advanced Gastric Carcinoma / T.Konishi et al. / p287～287
• 7'.Effects and Methods of Preoperative Chemotherapy in the Treatment of Pediatric Malignant Solid Tumors--With Emphasis on Continuous Intra-arterial Infusion of PGE / S.Ogita et al. / p288～288
• 7".Intraarterial Chemotherapy with Nor-Adrenalin The Third Report Supperselect Injection / T.Sato et al. / p288～288
• 8.Antitumor Effects of Intra-arterially Infused Biodegradable Microspheres Containing Mitomycin C / S.Fujimoto et al. / p288～288
• 8'.Effect of Arterial Administration of High-molecular weight Anticancer Agent SMANCS with Lipid Lymphographic Agent on Various Malignant Solid Tumors / T.Konno et al. / p288～289
• 8".Transcatheter Arterial Chemo-Embolizatian for Locally Advanced Breast Cancer / Y.Takatsuka et al. / p289～289
• 9."Two Route Infusion Chemotherapy" for Human Primary and Secondary Liver Cancer / R. Abe et al. / p289～289
• 9'.Intra-arterial Infusion Chemotherapy for Bladder Cancer with a Simultaneous Use of Direct Hemoperfusion (DHP)--Adsorption Capacity of Cis-Diammine Dichloro Platinum (CDDP) by DHP / T. Shimizu et al. / p290～290
• 9". Double Channel Chemotherapy with Intra-arterial Infusion of DDP and Concurrent Intra-venous Infusion of STS (Sodium Thiosulfate) for Bladder Cancer / H.Sekine et al. / p290～290
• 10.Pelvic Isolation Perfusion Hyperthermia / I.Yokoyama et al. / p290～290
• Panel Discussion 11 Parenteral Nutrition in Cancer Therapy / / p291～293
• 1.Intravenous Nutrition for Cancer Therapy / T.Itakura et al. / p291～291
• 2.A Study on Combined Chemo-therapy of Intra-venous Hyperalimentation for Advanced Gastro-intestinal Cancer / T.Yamasaki et al. / p291～291
• 3.Effect of Postoperative Total Parenteral Nutrition (TPN) as an Adjunct to Gastrectomy for Advanced Gastric Carcinoma / K.Hioki et al. / p291～291
• 4.Effect of Intravenous Hyperalimentation on Preoperative Radiation Therapy in the Patients with Esophageal Carcinoma / Y.Matsubara et al. / p292～292
• 5.Postoperative Combined Therapies for the Esophageal Carcinomas under the Support of Total Parenteral Nutrition (TPN) / T.Nishihira et al. / p292～292
• 6.Effects and Problems of Parental Hyperalimentation in Cancer Therapy--Evaluation from the Surgical Standpoint / K.Terabe et al. / p292～292
• 7.Usefulness of TPN in the Cancer Treatment / T.Sugita et al. / p293～293
• 8.The Treatment of Advanced Cancer with Amino Acid Imbalance / Y.Kawaura et al. / p293～293
• 9.Methionine and Cystine Free Amino-acid Imbalance as an Adjunct to Cancer Chem-otherapy / N.Goseki et al. / p293～293
• Panel Discussion 12 Alteration of Drug Type of Anti-cancer Agents / / p294～298
• 1.Phase II Study of Sustained Release Granules of Tegafur (SF-SP) / H.Satou et al. / p294～294
• 2.Comparison between Blood and Lymphatic Transport of Tegafur--Special Reference to Changes of Drug Type / H.Hanaue et al. / p294～294
• 3.Solubilization of Various Anticancer Agents in Lipid Contract Medium and Pharmacological Study / H.Maeda et al. / p294～294
• 4.Utility of Albumin Microspheres Containing Antitumor Agents in Cancer Chemotherapy / Y.Morimoto et al. / p295～295
• 5.Targeted Cancer Chemotherapy by Fat-emulsified 5FU and by Mitomycin C Adsorbed to Activated Carbon Particle / A.Hagiwara et al. / p295～295
• 6.New Type of Thrombotic Materials / A.Sugitachi et al. / p295～295
• 7.Clinical Evaluation of Tubed Solidified Bleomycin (TS-BLM) for Microscopical Treatment in the Surgery of Cancer of the Esophagus / H.Watanabe / p296～296
• 8.Studies on the Injected Therapy of PANa-oil-bleomycin in Nonresectable Esophageal Carcinoma (Comparative Study of the Resected Specimens) / Y.Kataba et al. / p296～296
• 9.Clinical Trial of Local Chemotherapy in Inoperable Pancreatic Cancer,Gall Bladder Cancer and Hepatoma / M.Nakamura et al. / p296～296
• 10.Microencapsules as a Means of Targeted Cancer Chemotherapy / T.Kato et al. / p297～297
• 11.Treatment of Prostatic Cancer with LH-RH Agonist(leuprolide)-copolymer Composite / H.Yamanaka et al. / p297～297
• 12.Developmental and Therapeutic Application of Intravesical Stick as Local Chemotherapy for Bladder Cancer / Y.Matsumoto / p297～297
• 13.Fundamental and Clinical Study of ADR Ointment / M.Fukuda et al. / p298～298
• Panel Discussion 13 Interferons / / p299～303
• 1.Clinical Study of Human Fibroblast Interferon(HFIF)and Human Lymphoblastoid Interferon(HLBI) / N.Usui et al. / p299～299
• 2.Treatment of Hematological Malignancies with Interferons / R.Ohno et al. / p299～299
• 3.Interferon Treatment on Patient with Advanced Cancer / H.Mugitani et al. / p299～299
• 4.Clinical Evaluation of Human Lymphoblastoid Interferon(HLBI)in the Treatment of Hepatic Tumor / N.Yoshioka et al. / p300～300
• 5.Antitumor Effect of Human Fibroblast Interferon(IFN-β)on Patient with Hepatocellular Carcinoma(HCC) / T.Okai et al. / p300～300
• 6.Early Phase II of γ IFN-αA(Ro22-8181)on the Patients with Urogenital Cancer / J.Yoshimoto et al. / p300～300
• 7.Clinical Evaluation of the Treatment with Interferon(IFN-α)Followed by OK-432 on the Advanced Renal Cell Carcinoma / M.Murai et al. / p301～301
• 8.Interferon Therapy for Malignant Brain Tumor Patients / S.Ueda et al. / p301～301
• 9.Combination Therapy of Interferon and Radiation to Malignant Brain Tumors / T.Arai et al. / p301～301
• 10.Preliminary Study of Children's Brain Tumors Treated by Interferon(IFN-α)and Radiation / T.Miyoshi et al. / p302～302
• 11.Bronchial Arterial Infusion(BAI)Therapy of IFN-β to Lung Cancer / H.Masuda et al. / p302～302
• 12.Clinical and Experimental Study on Enhancing Effect of IFN-α on Natural Killer(NK)Cell Activity / M.Hayakawa et al. / p302～302
• 13.Effect of Various Types/Sources of Interferons on Cytotoxic Activity of Lymphocyte / H.Dozono et al. / p303～303
• 14.Modulation of 5-Fu Induced Toxicity in C3H/He Mice with Interferon or with the Interferon Inducers / M.Akimoto et al. / p303～303
• Panel Discussion 14 Anti-cancer Agents of Anthracycline Lineage / / p304～306
• 1.Pharmacokinetics of 4'-Epiadriamycin and 4'-O-Tetrahydropyranyl-Adriamycin / H.Fujita et al. / p304～304
• 2.Clinical Comparative Study of THP-Adriamycin and 4'-Epiadriamycin / K.Ikeda et al. / p304～304
• 3.Comparative Studies of Cardiomyopathy Induced in Rabbits by Various Anthracyclines and Anthraquinone / N.Domae et al. / p304～304
• 4.A Comparative Study of 4'-Epidoxorubicin and Doxorubicin Cardiotoxicities / T.Suzuki et al. / p305～305
• 5.Clinical Effect of THP-ADM on Acute Leukemia and Malignant Lymphoma / Y.Tani et al. / p305～305
• 6.Aclarubicin(ACR)and a Combination of ACR,Vincristine,Cyclophosphamide and Prednisolone in the Treatment of Multiple Myeloma / T.Sezaki et al. / p305～305
• 7.Treatment with ADR and THP-ADR for Non Small Cell Lung Cancer--Including Randomized Trial / S.Negoro et al. / p306～306
• 8.Clinical Effect of 4'-O-Tetrahydropyranyl-Adriamycin(THP-ADM)on Gynecological Malignant Diseases / M.Suzuki et al. / p306～306
• 9.Antitumor Effects of Anthracyclines and Anthraquinone on Advanced Breast Cancer Patients / M.Kitamura et al. / p306～306
• Panel Discussion 15 Fluorinated Pyrimidine Derivatives / / p307～308
• 1.Influence of Uracil,Thymine and Thymidine on the Pharmacokinetics of Various Fluoropyrimidines--With special Reference to UFT / H.Fujita et al. / p307～307
• 2.Recent Advance of Gastrointestinal Cancer Chemotherapy with Oral Administration of Fluoropyrimidines / M.Yamamura et al. / p307～307
• 3.Enzymatic Activation of Tegafur and 5'-deoxy-5-fluorouridine(5'-DFUR)to 5-fluorouracil(5Fu)in Human Tumor Tissue / Y.Hara et al. / p307～307
• 4.Effect of Fluorinated Pyrimidine Derivatives against Primary Lung Cancer and Metastatic Pulmonary Tumor / E.Shimizu et al. / p308～308
• 5.Comparative Effect and Toxicity of Fluorinated Pyrimidine Derivatives--With Special Reference to 5'-deoxy-5-fluorouridine(5'-DFUR) / J.Ota et al. / p308～308
• 6.Clinical Trials of Two Derivatives of FUDR,2'-Deoxy-3',5'-o-acethyl-5-fluoro-3-(3-methylbenzoyl)uridine(FF-705)and 5-Fluoro-3(3,4-methylene-dioxybensoyl)-2'-deoxy-β-uridine(TK-117) / M.Matsumoto / p308～308
• Panel Discussion 16 Podophyllotoxin Derivatives / / p309～312
• 1.The Mechanism of Action of VP-16 / Y.Izumi et al. / p309～309
• 2.A Phase I Study of VP-16-213(VP)by a Single and 5-Day Infusion / M.Yokoyama et al. / p309～309
• 3.Phase I Study on Etoposide(NK 171),a Semisynthetic Derivative of Podophyllotoxin / K.Yamada et al. / p309～309
• 4.A Phase II Trial of VP-16-213 in Hematologic Malignancy / K.Sampi et al. / p310～310
• 5.Phase II Study of VP-16 / I.Tanaka et al. / p310～310
• 6.A Clinical Trial of Etoposide on Adult T-cell Leukemia/Lymphoma(ATLL)and Other Lymphoid Malignancies / M.Matsumoto / p310～310
• 7.Phase II Trial of VP16 in Far Advanced Lung Cancer / S.Yoneda et al. / p311～311
• 8.Clinical Experience of Etoposide(NK171)in Patients with Bronchogenic Carcinoma and Metastatic Pulmonary Tumors / K.Eguchi et al. / p311～311
• 9.Treatment with Etoposide to Pts with Far Advanced Lung Cancer / M.Takada et al. / p311～311
• 10.Combination Chemotherapy of Small Cell Lung Cancer with Vincristine,Etoposide and Cyclophosphamide / K.Aiba et al. / p312～312
• Panel Discussion 17 Cisplatin / / p313～316
• 1.Preclinical and Clinical Studies on Cisplatin Treatment for Head and Neck Cancer / Y.Inuyama et al. / p313～313
• 2.Cis-Dichlorodiammineplatinum(II)in Lung Cancer / N.Kodama et al. / p313～313
• 3.Effects of CDDP Administration on Treatment of Esophageal Cancer / Y.Koide et al. / p313～313
• 4.2 Channel Infusion Therapy of Cisplatin Using Balloon Catheter for Primary Liver Cancer / S.Onohara et al. / p314～314
• 5.Combined Cisplatin against Malignant Ovarian Tumors / A.Tsunawaki et al. / p314～314
• 6.Treatment of Advanced Testicular Tumors with BVP Regimen / I.Fukui et al. / p314～314
• 7.Pre-operative Cisplatin Chemotherapy in Osteosarcoma / S.Takeyama et al. / p315～315
• 8.Phase II Study of Cis-Dichlorodiammineplatinum(II)(CDDP)in Advanced Malignant Lymphomas / T.Ibuka et al. / p315～315
• 9.Evaluation of Cisplatin in Children with Advanced Malignant Tumors / A.Toyosaka et al. / p315～315
• 10.Efficacy Study of Cisplatin Based Chemotherapy in Bronchogenic Carcinoma / N.Hara et al. / p316～316
• General Lecture 1.Effects of Intravenous Hyperalimentation(IVH)on Tumor Growth and Tumor Response to P-Aminobenzoic Acid-N-Xyloside Sodium Salt(k-247) / K.Kishi et al. / p317～317
• General Lecture 2.Effect of Total Parenteral Nutrition(TPN)as an adjunct to Patients with Total Gastrectomy and Proximal Gastrectomy for Gastric Cancer and Patients with Recurrence Gastric Cancer / O.Kojima et al. / p317～317
• General Lecture 3.Effects of Intravenous Hyperalimentation Adjunct to the Anticancer Chemotherapy / M.Kimoto et al. / p317～317
• General Lecture 4.Effect of Preoperative Intravenous Hyperalimentation(IVH)on Nutritional Status and Immune Response in Esophageal Cancer Patients / T.Saito et al. / p318～318
• General Lecture 5.Postoperative Management of Advanced Cancer by IVH with Low Dose Heparin / K.Tari et al. / p318～318
• General Lecture 6.Preparation of Anti-Hela Cell Monoclonal Antibody by Cell Fusion / S.Sekiya et al. / p318～318
• General Lecture 7.Serum AFP Subfractions in Patients with Primary Hepatoma or Hepatic Metastasis of Gastric Cancer / T.Ishiguro et al. / p319～319
• General Lecture 8.Clinicopathological Study of 36 Cases of Alpha-fetoprotein Positive Gastric Cancer / A.Usui et al. / p319～319
• General Lecture 9.Clinical Value of Basic Fetoprotein in Malignant Digestive Diseases / Y.Kanda et al. / p319～319
• General Lecture 10.Evaluation of Prostate-specific Antigen in Prostate Cancer / T.Takeuchi et al. / p320～320
• General Lecture 11.Antibody Response against CALLA in Children with Acute Lymphoblastic Leukemia(ALL)Receiving Specific Active Immunotherapy / E.Azuma et al. / p320～320
• General Lecture 12.Evaluation of a Pancreatic Oncofetal Antigen(POA)in Patients with Carcinoma and Benign Disease of the Pancreas / S.Hishinuma et al. / p320～320
• General Lecture 13.Evaluation of Tumor Markers for Carcinoma of the Pancreas / N.Kuno et al. / p321～321
• General Lecture 14.Clinical Evaluation of Serum Tissue Polypeptide Antigen(TPA)Concentration in Patients with Malignancy of the Digestive System / H.Sakahara et al. / p321～321
• General Lecture 15.A Study of Serum TPA in Patients with Gastric Cancer / Y.Otani et al. / p321～321
• General Lecture 16.Gastric Cancer and Tumor Markers / Y.Uehara et al. / p322～322
• General Lecture 17.Studies on Tissue Polypeptide Antigen in Patients with Gastric Cancer / K.Sakamoto et al. / p322～322
• General Lecture 18.Comparative Study of Serum Levels of TPA, CEA and Ferritin on Colorectal Cancer Patients / Y.Takata et al. / p322～322
• General Lecture 19.Tissue Polypeptide Antigen in Breast Cancer / T.Nomizu et al. / p323～323
• General Lecture 20.Studies on Tissue Localization of Tumor-markers in Ovarian Tumors by Immunoperoxidase Method / T.Tanimura et al. / p323～323
• General Lecture 21.Assessment of Diagnostic Efficacy of Plasma Tissue Polypeptide Antigen as a Tumor Marker--Comparison with Other Markers and Their Combined Use / D.Tsujino et al. / p323～323
• General Lecture 22.Clinical Evaluation of a Serum Tissue Polypeptide Antigen(TPA)in Patients with Solid Cancer--In Comparison with Other Tumor Markers / J.Matsui et al. / p324～324
• General Lecture 23.Hematoporphyrin Derivative(HpD)Uptake and Photoinactivation in in vitro Cultivated Human Bladder Cancer Cells(KK-47) / O.Ueki et al. / p324～324
• General Lecture 24.Fundamental Studies of Photoradiation Therapy on Human Cancer Cells in vitro in the Presence of Hematoporphyrin / T.Kuwahara et al. / p324～324
• General Lecture 25.Photoradiation Therapy(PRT)for Experimental Tumor Using Excimer Dye Laser / M.Otawa et al. / p325～325
• General Lecture 26.Thermal Considerations on Laser Photodynamic Treatment / M.Yonekawa et al. / p325～325
• General Lecture 27.Optical Properties of Malignant Patients' Blood under Ar-Laser Line at DC Magnetic Field / H.Hayashi et al. / p325～325
• General Lecture 28.Clinical Studies on Laser Endoscopy for Treatment of Superficial Esophageal Cancer:Argon-Dye Laser in Combination with HpD / T.Hirashima et al. / p326～326
• General Lecture 29.Endoscopic Photoradiation Therapy for Esophageal Cancer / N.Okushima et al. / p326～326
• General Lecture 30.Photoradiation Therapy in the Treatment of Respiratory Malignancy / K.Furuse et al. / p326～326
• General Lecture 31.Pathological Examination of Resected Specimens of Central Type Early Squamous Cell Carcinoma after Laser Treatment / R.Amemiya et al. / p327～327
• General Lecture 32.Photoradiation Therapy of Lung Cancer by Argon Laser / K.Fujioka et al. / p327～327
• General Lecture 33.Combined Therapy of Laser Radiation and Immunochemotherapy for Cancerous Stenosis / S.Akazawa et al. / p327～327
• General Lecture 34.Application of Laser Surgery for Malignant Tumor of Digestive System / F.Sano et al. / p328～328
• General Lecture 35.Fundamental and Clinical Studies of Photoradiation Therapy in Gynecological Malignancies / T.kasai et al. / p328～328
• General Lecture 36.Treatment of Neoplasms in the Uterine Cervix by CO₂-laser / K.Sakamoto et al. / p328～328
• General Lecture 37.Enhancement by Hyperthermia of the in vitro Cytotoxicity of Anticancer Drugs on Human Lung Epidermoid Carcinoma Cells / T.Seto et al. / p329～329
• General Lecture 38.Effect of Hyperthermia on KK-47 Human Bladder Cancer Cells Hetero-transplanted in Nude Mice / Y.Saitoh et al. / p329～329
• General Lecture 39.Experimental Studies of Regional Hyperthermia on MH134 Tumor under Various Conditions of Heating / Y.Matsuzaki et al. / p329～329
• General Lecture 40.Hyperthermia for Experimental Colon Carcinoma of Dogs / T.Kamano et al. / p330～330
• General Lecture 41.Fundamental Study of RF Hyperthermia / A.Sugiyama et al. / p330～330
• General Lecture 42.Regional Hyperthermo-chemotherapy with in-vivo Isolated Liver Perfusion for the Treatment of Liver Tumors in the Rats / M.Miyazaki et al. / p330～330
• General Lecture 43.Radio-chemo-thermal Treatment for Advanced Hepato-choledoco-pancreatic Tumors / T.Yamashita et al. / p331～331
• General Lecture 44.Hyperthermo-chemotherapy for Peritoneal Dissemination of Cancer by Peritoneal Perfusion / N.Mizuguchi et al. / p331～331
• General Lecture 45.Combination Thermotherapy of Systemic Hyperthermia Plus Local R.F.Heating / N.Kato et al. / p331～331
• General Lecture 46.Studies on Preoperative Combined Therapy with Hyperthermia for Esophageal Cancer / A.Hanaoka et al. / p332～332
• General Lecture 47.The Application of Induction Heating in Lesional Hyperthermia in Combination with Ferromagnetic Microembolization(FME) / M.Sako et al. / p332～332
• General Lecture 48.Total Body Hyperthermia by Use of V-A By-pass Extracorporeal Circulation / H.Kawahara et al. / p332～332
• General Lecture 49.Clinical Study for Local Hyperthermia / M.Tsumura et al. / p333～333
• General Lecture 50.WHO Cancer Pain Relief Programme--Introduction of WHO Draft Interim Guideline and Its Field Testing / F.Takeda / p333～333
• General Lecture 51.Analgesic Effect of Calcitonin on Patients with Bone Metastases of Breast Cancer / M.Kimura et al. / p333～333
• General Lecture 52.Particular Aspects of Terminal Care in the Patients of Head and Neck Cancers / I.Ono et al. / p334～334
• General Lecture 53.A New Treatment Method for Advanced Head and Neck Cancers / H.Takahashi et al. / p334～334
• General Lecture 54.Mass Screening for Breast Cancer:Examination Rate and Detection Rate by Age Groups / N.Ueda et al. / p334～334
• General Lecture 55.Comparative Study of the Mass Screening for Breast Cancer between Two Cities Located in the Sea Shore and Inland Area / R.Abe et al. / p335～335
• General Lecture 56.The Process and Project of Mass Screening for Breast Cancer in Miyagi Prefecture / K.Yoshida et al / p335～335
• General Lecture 57.The Breast Cancer Screening Survey in Kanagawa Prefecture(The Third Report) / H.Takemura et al. / p335～335
• General Lecture 58.The Breast Cancer Screening Survey in Yokohama City(The Second Report) / T.Suda et al. / p336～336
• General Lecture 59.Five Years Experience with Mass Screening for Thyroid Cancer / M.Tsuyuguchi et al. / p336～336
• General Lecture 60.Mass Screening for Colorectal Cancer Using Occult Fecal Blood Testing / J.Ota et al / p336～336
• General Lecture 61.Mass Screening of Neuroblastoma in Infancy / T.Takeda et al. / p337～337
• General Lecture 62.Colposcopic Findings of Pregnant Women / T.Horii et al. / p337～337
• General Lecture 63.Pre-operative Diagnosis for Stage II Endometrial Carcinoma Using Endocervical Conization / K.Fukuda et al. / p337～337
• General Lecture 64.Determination of Cancer Residue after Conization and Selection of Follow up Cases / Y.Sakaguchi et al. / p338～338
• General Lecture 65.Preoperative Diagnosis for Cervical Carcinoma by Using Punch Biopsy ,Cytology and Colposcopic Findings / H.Iwasaki et al. / p338～338
• General Lecture 66.Evaluation of Biopsy for Choriocarcinoma / T.Tanaka et al. / p338～338
• General Lecture 67.Gynecological Application of the Deep Body Thermometer / M.Sato et al. / p339～339
• General Lecture 68.In vivo Measurement of Electrical Bio-impedance on Breast Tumors / K.Nishimoto et al. / p339～339
• General Lecture 69.Biopsy for Breast Cancer / F.Takaekoh et al. / p339～339
• General Lecture 70.Microcalcification Related to Blunt Duct Adenosis of the Breast / M.Hiratsuka et al. / p340～340
• General Lecture 71.The Parenchymal Patterns of Breast as Risk Factors for Breast Cancer / T.Majima et al. / p340～340
• General Lecture 72.Development of Contact-Micro-Cystoscopy The First Report: Observation of the Bladder Epithelium with Contact-Micro-Colpohysteroscope / M.Nakao et al. / p340～340
• General Lecture 73.Brushing Cytology in Renal Pelvic and Ureteral Tumors / T.Okano et al. / p341～341
• General Lecture 74.Multiple Mucosal Biopsy for Bladder Carcinoma / M.Igawa et al. / p341～341
• General Lecture 75.Hepatocellular Carcinoma with Concomitant Obstructive Jaundice of 17-year-old Male--A Case Report / H.Kohno et al. / p341～341
• General Lecture 76.An Experience of Therapy for Leiomyosarcoma of the Retroperitoneal Cavity / H.Fukasawa et al. / p342～342
• General Lecture 77.Pregnancy Following Removal and Chemotherapy of Ovarian Embryonal Carcinoma(Higuchi-Kato)Group C(Mixed Germ Cell Tumor) / J.Saito et al. / p342～342
• General Lecture 78.Carcinoma in situ of the Vulva / T.Saito et al. / p342～342
• General Lecture 79.Endometrial Stromatosis--A Case Report / I.Shiozawa et al. / p343～343
• General Lecture 80.A Case of Adenoid Cystic Carcinoma Arising from Bartholin's Gland--A Case Report and Review of Literatures / T.Sugiyama et al. / p343～343
• General Lecture 81.The Effects of Lentinan Injection on the Adrenalectomized Rats Bearing DMBA-induced Mammary Tumor and Human Mammary Cancer / A.Kosaka et al. / p343～343
• General Lecture 82.Enhancement of Immunocompetence of Local Lymph Nodes by Local Infusion of PSK / H.Funahashi et al. / p344～344
• General Lecture 83.Anticarcinogenic Actions of Water-soluble and Alcohol-insoluble Fractions from Culture Medium of Lentinus Edodes Mycelia / K.Tazawa et al. / p344～344
• General Lecture 84.Immunotherapy by Using N-CWS in Postoperative Gastric Cancer Patients / S.Koyama et al. / p344～344
• General Lecture 85.The Statistical Analysis of Advanced Cancer Patients in Treatment with an Extract from Human Tubercle Bacilli(S.S.M.)--Report V / K.Fujita et al. / p345～345
• General Lecture 86.In vitro Antiproliferative Activity of Interferon against Bladder Carcinoma Cell Lines / T.Nasu et al. / p345～345
• General Lecture 87.Changes of NK and ADCC Activities in Cancer Patients Treated with Recombinant Human Leukocyte Interferon A / K.Domoto et al. / p345～345
• General Lecture 88.Inhibitory Effect of IFN-Cyclophosphamide Therapy on the Growth of Tumor Trans-planted in Nude Mice / M.Takada et al. / p346～346
• General Lecture 89.Effect of Interferon in the Treatment of Malignant Tumors / O.Nakamura et al. / p346～346
• General Lecture 90.Increased Cytotoxicity Effects of Various Anticancer Drugs by α-interferon(HLBI)on Human Tumor Xenografts in Nude Mice / Y.Nosoh et al. / p346～346
• General Lecture 91.Clinical Evaluation of HLBI(Human Lymphoblastoid Interferon)on the Treatment of Multiple Myeloma / Y.Matsuura et al. / p347～347
• General Lecture 92.Chemotherapy of Renal Cell Carcinoma 4.Interferon / Y.Satomi et al. / p347～347
• General Lecture 93.HLBI(Human Lymphoblastoid Interferon)Therapy on Metastatic Lesion of Renal Cell Carcinoma / H.Natsume et al. / p347～347
• General Lecture 94.Clinical Evaluation of Interferon-β and-α on the Treatment of Thyroid Cancer / I.Nagata et al. / p348～348
• General Lecture 95.Multidisciplinary Treatment with Interferon Inducer,Ge-132,in Our Department / H.Fukazawa et al. / p348～348
• General Lecture 96.Pharmacologic Studies of Cisplatin / M.Sawada et al. / p348～348
• General Lecture 97.Efficacy of Cisplatin (IP)+Sodium Thiosulfate(SC)on Peritonitis Carcinomatosa of Nude Mice Transplanted Human Gastric Cancer / S.Takao et al. / p349～349
• General Lecture 98.Clinical and Fundamental Analysis of Cis-Diamminedichloroplatinum(II)(CDDP)Therapy by Measuring Tissue CDDP Concentration / S.Kodama et al. / p349～349
• General Lecture 99.Analysis of Effect of C-DDP on Kinetic Change of DNA & RNA in Cultured Cells / T.Ishibashi et al. / p349～349
• General Lecture 100.Clinical Study of Cis-Platinum 1.Clinical Pharmacokinetics and Toxicities of Cis-Platinum in Children / K.Sasaki et al. / p350～350
• General Lecture 101.Ultrastructural Observation on DDP Drug Action to Urological Cancers in Nude Mice / K.Yoshida et al. / p350～350
• General Lecture 102.Intraperitoneal Administration of Cisplatin and Protease Inhibitor for Peritonitis Carci-nomatosa in the Mice / T.Kurokawa et al. / p350～350
• General Lecture 103.Cytocidal Effect of CDDP on Malignant Brain Tumor Cells and Pharmacokinetics / Y.Fujioka et al. / p351～351
• General Lecture 104.Pharmacokinetic Study in Combination Therapy with CDDP and PEP--Interaction with Plasma Protein / M.Fujii et al. / p351～351
• General Lecture 105.Anti-tumor Effects and Plasma Platinum Levels in the Combination Therapy of Cis-platinum with Thiosulfate / M.Maeta et al. / p351～351
• General Lecture 106.Combined Chemotherapy with Cisplatin and Bleomycin for Malignant Tumor of the Chest / Y.Saitoh et al. / p352～352
• General Lecture 107.CMAF(Cis-platinum Combined with Mitomycin C, Adriamycin and 5-FU) in the Treatment of Lung Cancer and Non-epithelial Cell Carcinomas / T.Tatsumura et al. / p352～352
• General Lecture 108.Clinical Response and Toxicity with cis-Dichlorodiammineplatinum(II)in Primary and Metastatic Lung Cancer Patients / K.Tominaga et al. / p352～352
• General Lecture 109.Clinical Study of Combination Chemotherapy with CDDP,PEP,MMC(PPM Therapy)and CDDP,5-FU,MMC(PFM Therapy)for Non-small Cell Lung Cancer / T.Goto et al. / p353～353
• General Lecture 110.Cisplatin and Bleomycin in the Treatment of Squamous Cell Carcinoma of the Lung / A.Yokoyama et al. / p353～353
• General Lecture 111.TPA,CEA and IAP Levels in Gynecological Cancer / S.Saitoh et al. / p353～353
• General Lecture 112.Clinical Significance of Tissue Polypeptide Antigen in Patients with Cervical Cancer / Y.Yanagawa et al. / p354～354
• General Lecture 113.Clinical Significance of Tissue Polypeptide Antigen(TPA)in Gynecologic Malignant Diseases / K.Kato et al. / p354～354
• General Lecture 114.Multiple Tumor Markers in Patients with Gynecologic Malignancies / Y.Inoue et al. / p354～354
• General Lecture 115.Study of Tumor Markers(hCG,SP1,PP5,TPA)in Trophoblastic Disease / K.Isaka et al. / p355～355
• General Lecture 116.Study on Immunotherapy and Immunodetection Using Anti-CEA Antibody in Gastro-intestinal Cancer / A.Ohashi et al. / p355～355
• General Lecture 117.Immunohistochemical Detection of Carcinoembryonic Antigen in Benign Hyperplasia and Adenocarcinoma of the Prostate with Monoclonal Antibody / M.Ghazizadeh et al. / p355～355
• General Lecture 118.Role of Plasma CEA Levels in Evaluating Breast Cancer Patient Status / K.Hisamatsu et al. / p356～356
• General Lecture 119.Lung Cancers and Their Serum CEA Levels / M.Suyama et al. / p356～356
• General Lecture 120.Differential Diagnosis of the Cases with Pleural Effusions / M.Ogino et al. / p356～356
• General Lecture 121.Tissue Carcinoembryonic Antigen in Uterine Cervical Cancer / H.Kitagawa et al. / p357～357
• General Lecture 122.A New Serological Diagnostic Method for Malignant Tumors of Germ Cell Origin / K.Higaki et al. / p357～357
• General Lecture 123.Plasma Exchanges in Patients with Advanced Cancer:Reference to the Elimination of Serum Immunosuppressive Factors by Filtration / K.Nakanishi et al. / p357～357
• General Lecture 124.Clinical Effects of Plasmapheresis for Recurrent Carcinoma of the Large Intestine / N.Azuma et al. / p358～358
• General Lecture 125.Plasma Exchange for the Cancer-bearing Patients in Terminal Stage / T.Tani et al. / p358～358
• General Lecture 126.Double Filtration Plasmapheresis in Patients with Renal Cell Cancer / A.Yamasaki et al. / p358～358
• General Lecture 127.Selective Removal of Immunosuppressive Factors by Double Filtration Plasmapheresis(DFPP)in Cancer Patients / M.Miyazaki et al. / p359～359
• General Lecture 128.Studies on the Host Immune Response in Rat during Induction of Bladder Tumors by BBN / Y.Ozaki et al. / p359～359
• General Lecture 129.Leukocyte Migration Inhibition(LMI) of Murine Spleen Cells after Immunization with Tumor Cells 2.Assessment with LMI in Combination Therapy with a Non-specific Immunostimu-lant and a Chemotherapeutic Agent / T.Umeda et al. / p359～359
• General Lecture 130.Direct Antitumor Activity of Biological Response Modifiers(B.R.M.)Proven by Our in vitro Sensitivity Test / T.Yanagawa et al. / p360～360
• General Lecture 131.Effect of Organic Germanium Compound,GE-132 on NK Activity of Peripheral Blood Lymphocytes from Cancer Patients / J.Ohida et al. / p360～360
• General Lecture 132.NK Cell Activity and Adjuvant Chemo-immuno Therapy of the Colorectal Carcinoma / T.Jo et al. / p360～360
• General Lecture 133.Specific Active Immuno-chemotherapy with a Solublized Tumor Antigen / M.Kobayashi et al. / p361～361
• General Lecture 134.Chemoimmunotherapy of Implanted Murine Bladder Cancer / H.Akaza et al. / p361～361
• General Lecture 135.Immunochemotherapy against Human Malignant Brain Tumors Transplanted into Nude Mice / T.Hori et al. / p361～361
• General Lecture 136.The Effect of Bestatin on Experimental Lingual Cancer / N.Akazawa et al. / p362～362
• General Lecture 137.Anti-tumor Activity of Cimetidine / Y.Ito et al. / p362～362
• General Lecture 138.The Effect of Cimetidine on NK Cell Activity and Responsiveness to PHA of PBL in Patients with Gynecologic Malignancies / Y.Kikuchi et al. / p362～362
• General Lecture 139.Inpact of the Oral Administration of OK-432 and Nutritional Status on Antitumor Activity and Antimetastatic Effect in Regional Lymph Nodes in C3H/He Mice / Y.Nakajima et al. / p363～363
• General Lecture 140.Immunological Studies of the Cervical Lymph Nodes in Oral Cancer Patients / Y.Ichikawa et al. / p363～363
• General Lecture 141.Localization of Lymphocyte in Uterine Cervical Cancer / S.Shiraki et al. / p363～363
• General Lecture 142.The Change of Electrophoretic Activity of Peripheral Lymphocytes in Cancer Patients (The Second Report) / T.Mori et al. / p364～364
• General Lecture 143.Changes in the Electrophoretic Mobility of Lymphocytes in Cancer Patients and Its Clinical Significance / M.Maeno et al. / p364～364
• General Lecture 144.Influences of Operative Intervention on NK Activity and the Effect of OK-432 Administration Evaluated by NK Activity Experimental Analysis Using Rat's Mammary Tumor(MRMT-1) / H.Oshita et al. / p364～364
• General Lecture 145.Prophylactic Effect of OK-432 for Experimental Models of Peritoneal Carcinomatosis / T.Iijima et al. / p365～365
• General Lecture 146.Augmentation of Natural Killer Activity of Abdominal Lymph Nodes in C3H/He Mice by the Oral Immunotherapy with OK-432 / M.Akimoto. / p365～365
• General Lecture 147.Oral Administration of Streptococcal Preparation OK-432--Enhancement of Natural Killer(NK)Activity and Mitogen Response / Y.Nio et al. / p365～365
• General Lecture 148.Study on Urogenital Cancer Immunotherapy with OK-432:Common Antigenicity between either Animal or Human Tumors and OK-432 / T.Fujioka et al. / p366～366
• General Lecture 149.Effect of Intralymphatic Administration of OK-432 for Advanced Cancer / N.Takahashi et al. / p366～366
• General Lecture 150.The Effect of OK-432 Preoperative Intratumoral Injection / A.Gouchi et al. / p366～366
• General Lecture 151.Prognostic Significance of Massive Intratumoral Injection of OK 432 in Unresectable Cancer of the Pancreas / I.Mizuno et al. / p367～367
• General Lecture 152.Intraperitoneal Administration of OK 432 to Gynecological Malignant Ascites / S.Honma et al. / p367～367
• General Lecture 153.Effect of Immunotherapy Using OK 432 for Malignant Ovarian Tumor / T.Kano et al. / p367～367
• General Lecture 154.Clinical Evaluation of the Su-PS Skin Reaction in Post-Operative Immunotherapy with OK-432 in Oral Cancer Patients / M.Odani et al. / p368～368
• General Lecture 155.Clinical Value of Immunotherapy by Streptococcal Preparation OK-432 for Lung Cancer--Randomized Study / Y.Watanabe et al. / p368～368
• General Lecture 156.Immunochemotherapy of Gastric and Colorectal Cancer-effect of Intradermal Injection of OK-432 / T.Kajitani et al. / p368～368
• General Lecture 157.Effect of OK-432 on Bone Marrow Suppression Caused by Anti-cancer Chemotherapy / T.Tsurumi et al. / p369～369
• General Lecture 158.The Postoperative Follow-up Study of Non-curative Gastric Resection Treated by Immunochemotherapy in Gastric Cancer / Y.Suda et al. / p369～369
• General Lecture 159.Clinical Effect of Immunochemotherapy with K-247 on Stomach Cancer / K.Ogoshi et al. / p369～369
• General Lecture 160.Adjuvant Immunochemotherapy for Patients with Stomach Cancer / K.Ogoshi et al. / p370～370
• General Lecture 161.A Study of Combined Method with a Large Quantity of Uronase in the Case of Inoperative Gastric Cancer / T.Yamada et al. / p370～370
• General Lecture 162.The Effect of Immuno-chemotherapy for Peritonitis Carcinomatosa / Y.Watanabe et al. / p370～370
• General Lecture 163.Comparative Observation on Effective and Uneffective Cases Performed Specific Immunotherapy in Cancer Patients / K.Takashima et al. / p371～371
• General Lecture 164.Study on Changes in Cellular Immune Reactivities in the Patients of Advanced Cervical Cancer after Treatment Part5 :Cellular Immune Reactivities in Recurrent or Dead Cases / K.Hasegawa et al. / p371～371
• General Lecture 165.Study of Adverse Effects Induced by Combined Therapy of Cyclophosphamide(CPA)and PSK / Y.Yamamura et al. / p371～371
• General Lecture 166.Effect of Cancer Immunotherapy and Reflection on Our Experience / T.Ohgane et al. / p372～372
• General Lecture 167.Immunoadsorption of IgG or Its Complexes Using the Newly-devised Protein A Column / M.Sakita et al. / p372～372
• General Lecture 168.The Cytotoxic Activity of Tumor Infiltrating Lymphocyte(TIL)and Its Application for Adoptive Immunotherapy / T. Hori et al. / p372～372
• General Lecture 169.Transfer Factor Immunotherapy for Primary Lung Cancers / T.Fujisawa et al. / p373～373
• General Lecture 170.Antitumor Effect of Schizophyllan(SPG)on Macrophage Activity / H.Itoh et al. / p373～373
• General Lecture 171.Clinical Evaluation of SPG on Advanced Gastric Cancer / I.Nakao et al. / p373～373
• General Lecture 172.Adjuvant Immunochemotherapy with SPG for Patients with Resectable Gastric Cancer / S.Fujimoto et al. / p374～374
• General Lecture 173.Clinical Evaluation of SPG on Patients of Cervical Cancer with Irradiation Therapy / I.Kohno et al. / p374～374
• General Lecture 174.Basic Study on Brain Tumor Therapy Using Mumpus Virus / N.Oka et al. / p374～374
• General Lecture 175.Not Received / /
• General Lecture 176.Prolongation of Survival Periods and Reevaluation of Immunological Parameters in Cancer Patients of the Gastrointestinal Tract Treated with Nonspecific Immunotherapy / H.Hanaue et al. / p375～375
• General Lecture 177.Effect of Chemo-and Immunochemo-therapy on Highly Advanced Gastric(Stage IV)and Colorectal(Stages IV&V)Cancer / Y.Tabuchi et al. / p375～375
• General Lecture 178.In vitro Sensitivity Test of Human Tumor Stem Cells to Anticancer Drugs / M.Usugane et al. / p375～375
• General Lecture 179.A Clinical Study of the Clonogenic Assay / T.Kubota et al. / p376～376
• General Lecture 180.An Evaluation of Anticancer Drugs against Xenotransplantable Human Prostatic Cancer(PC-3)by Clonogenic Assay / K.Ohmura et al. / p376～376
• General Lecture 181.In vitro Chemosensitivity Study of Urologic Malignancies by Clonogenic Assay / T.Hashimura et al. / p376～376
• General Lecture 182.Chemosensitivity Test of Urologic Malignancies with in vitro Stem Cell Assay / T.Sakuramoto et al. / p377～377
• General Lecture 183.Correlationship between Human Tumor Stem Cell Assay in vitro and Clinical Effects in vivo / N.Yamamoto et al. / p377～377
• General Lecture 184.Basic Study on a New Sensitivity Test against Anticancer Agents for Brain Tumor Cells Using Flow Cytometry(FCM) / K.Kawakami et al. / p377～377
• General Lecture 185.The Drug Sensitivity in vitro of Human Small Cell Carcinoma Cells and It's Clinical Application / S.Kobayashi et al. / p378～378
• General Lecture 186.Sensitivity Assay of Anti-cancer Agents with Suppression of ³H-TdR Uptake of Cancer Cells in Breast Cancer / T.Inamoto et al. / p378～378
• General Lecture 187.In vitro and in vivo Chemosensitivity Tests of Human Colon Carcinoma Strains / M.Watanabe et al. / p378～378
• General Lecture 188.A Study of Comparative Chemosensitivity in Exponential-versus Plateau-Phase Cultures of KN-41 Renal Cancer Cells / A.Nishino et al. / p379～379
• General Lecture 189.Sensitivity of Anti-cancer Agents against Human Gastrointestinal Cancer Transplanted into Nude Mice / M.Yamauchi et al. / p379～379
• General Lecture 190.Evaluation of Chemotherapy for Human Pancreatic Carcinoma Xenografts / H.Hisano et al. / p379～379
• General Lecture 191.Cell Kinetics and Chemosensitivity of the Human Carcinomas Serially Transplanted into Nude Mice / T.Inada et al. / p380～380
• General Lecture 192.Correlation between in vitro Chemosensitivity of Human Tumors and the Corresponding Xenografts in Nude Mice / Y.Mizuno et al. / p380～380
• General Lecture 193.Clinical Management of Prostatic Cancer--Results of Chemotherapy / K.Kubota et al. / p380～380
• General Lecture 194.Enhancement of Methotrexate Cytotoxicity under the Insulin Addition in Human Choriocarcinoma Cells in vitro / T.Hirama et al. / p381～381
• General Lecture 195.Basic and Clinical Study on Treatment for Refractory Choriocarcinoma / O.Kobayashi et al. / p381～381
• General Lecture 196.Effects of Bleomycin-Mitomycin Therapy for Lung Metastasis of Uterine Cervical Cancer / M.Mimura et al. / p381～381
• General Lecture 197.Clinical Analysis of Cervical Adenocarcinoma / M.Inagaki et al. / p382～382
• General Lecture 198.Clinical Study of Cervical Cancer in Oita Prefectural Hospital (1965～1982) / I.Taniguchi et al. / p382～382
• General Lecture 199.Prognostic Significance of Depth of Tumor Invasion / T.Inoue et al. / p382～382
• General Lecture 200.Study of Relapse in the Patients with Trophoblastic Tumors / K.Hirokawa et al. / p383～383
• General Lecture 201.Study on the Metastasis of a Choriocarcinoma to the Brain / T.Fuchi et al. / p383～383
• General Lecture 202.Late Recurrences of Ovarian Epithelial Carcinoma / Y.Matsumoto et al. / p383～383
• General Lecture 203.Combination Chemotherapy of Advanced Ovarian Cancer / H.Iwasawa et al. / p384～384
• General Lecture 204.VAB III Treatment of Advanced Endodermal Sinus Tumors with Liver Metastases / N.Tsukamoto et al. / p384～384
• General Lecture 205.Adjuvant Therapy for Ovarian Cancer with Marked Ascites (Effect of Intraperitoneal In-jection of OK 432 and t-AMCHA) / I.Kizawa et al. / p384～384
• General Lecture 206.UFT-M Chemotherapy for Ovarian Cancer(No.2) / Y.Uchida et al. / p385～385
• General Lecture 207.Comparative Study of m-Gastric Carcinoma and sm-Gastric Carcinoma / S.Kanabe et al. / p385～385
• General Lecture 208.Results of Surgical Treatment of Similar Early Gastric Cancer in 82 Patients / K.Azekura et al. / p385～385
• General Lecture 209.Comparison of 2 Types of Gastric Cancer / K.Matsumura et al. / p386～386
• General Lecture 210.Pathological Feature and X ray Diagnosis of the Gastric Cancer with Esophageal Invasion / T.Ogino et al. / p386～386
• General Lecture 211.Not Received / /
• General Lecture 212.Studies of Lymphatic Flow of Gastric Carcinoma to Para Aortic Nodes / M.Yoshida et al. / p386～386
• General Lecture 213.Study on Perigastric Lymphatic Circulation by Preoperative Endoscopic Injection of India Ink in Gastric Wall Around Cancer Lesion / H.Isozaki et al. / p387～387
• General Lecture 214.Liver Metastasis of Gastric Cancer / K.Yoshikawa et al. / p387～387
• General Lecture 215.Diagnosis of Liver Metastasis in Patients with Gastric Cancer:Reliability in Various Laboratory and Radiological Tests Including 5-NPD V(5-Nucleotide Phosphodiesterase Isoenzyme V)Assay and Intraoperative Ultrasonography / H.Kenmizaki et al. / p387～387
• General Lecture 216.A Clinicopathological Study of Postoperative Bone Metastasis in Resected Gastric Cancer / O.Izuno et al. / p388～388
• General Lecture 217.The Clinicopathological Study of the Lymphnode Metastasis of the Head of the Pancreas / R.Ohyama et al. / p388～388
• General Lecture 218.Clinicopathological Studies on Percutaneous Transhepatic Biopsy of Biliary Tract / S.Toyoda et al. / p388～388
• General Lecture 219.Histopathological Investigation on Oral Precancerous Lesions, IV / K.Tsuchikawa et al. / p389～389
• General Lecture 220.Studies on the Host-tumor Relationship in Oral Cancer 1.Clinical Diagnosis and Primary Lesions / T.Tagami et al. / p389～389
• General Lecture 221.Parapharyngeal Space Invasion of Head and Neck Cancer / M.Okuda et al. / p389～389
• General Lecture 222.The Relation between the Cervical Lymphnodes Metastasis and the Prognosis of Cancer of the Head and Neck / M.Asai et al. / p390～390
• General Lecture 223.A Retrospective Review of Distant Metastases of Nasopharyngeal Carcinoma / K.Iida et al. / p390～390
• General Lecture 224.Incidents of Metastases in Relatively Small Carcinomas of the Tongue with Vascular Involvement / T.Matsushima et al. / p390～390
• General Lecture 225.Clinicopathological Study on Renal Cell Carcinoma / S.Naito et al. / p391～391
• General Lecture 226.Pathological Investigation of Renal Cell Carcinoma / S.Nakanishi et al. / p391～391
• General Lecture 227.Clinico-Pathological Research of Renal Cell Carcinoma 3.Histopathological View and Clinical Characteristics of Grade 2 & 3 / Y.Senga et al. / p391～391
• General Lecture 228.Clinicopathological Study of Prostatic Carcinoma VI: Application of Gleason's Grading to the Cases in Japan with Reference to VACURG Studies / K.Uchida et al. / p392～392
• General Lecture 229.Flow Cytometric Analysis in the Diagnosis and Classification of Urogenital Malignancies / T.Yamauchi et al. / p392～392
• General Lecture 230.Surface Phenotype,Clinical Characteristics and Chemotherapy Effects of Acute Lymphocytic Leukemia in Adult / T.Koh et al. / p392～392
• General Lecture 231.Metastatic Patterns and an Indication of Treatment for Metastatic Lesions of Germ Cell Tumors of Testis / H.Saitoh et al. / p393～393
• General Lecture 232.Clinical and Pathological Study on Various Metastases Secondary to Nephrected Renal Cell Carcinoma / T.Ohnishi et al. / p393～393
• General Lecture 233.Brain Metastasis from Renal Cell Carcinoma / F.Masuda et al. / p393～393
• General Lecture 234.Silent Brain Metastasis / J.Uki et al. / p394～394
• General Lecture 235.The Study on Metastasis of Carcinoma of Uterine Cervix to Skin / A.Kurokawa et al. / p394～394
• General Lecture 236.The Vaginal Spread of Cervical Carcinoma / N.Chen et al. / p394～394
• General Lecture 237.Histogenic Difference between the Metaplastic Change and the Bulky Outgrowth in C.I.S. / T.Muroya et al. / p395～395
• General Lecture 238.Clinicopathological Findings and Spread of Uterine Cervical Cancer / K.Shibata et al. / p395～395
• General Lecture 239.A Study on Subclassification of Squamous Cell Carcinoma of the Uterine Cervix / Y.Sakai et al. / p395～395
• General Lecture 240.Clinical Significance of Nuclear DNA Pattern in Uterine Cervical Adenocarcinoma / Y.Hayashi et al. / p396～396
• General Lecture 241.Effect of 1-Hexylcarbamoyl-5-Fluorouracil(HCFU)and 1-(2-Tetrahydrofuryl)-5-Fluorouracil(Tegafur)on Transplantable Human Gastric Cancers in BALB/c Nude Mice / R.Akimoto et al. / p396～396
• General Lecture 242.Antitumor Effect of α-Difluoromethylornithine(DFMO)against a Human Tumor Xenograft(MX-1)Serially Transplanted into Nude Mice / F.Asanuma et al. / p396～396
• General Lecture 243.Chemotherapy of Human Pseudo Myxoma Transplanted in the Nude Mice / K.Miyahara et al. / p397～397
• General Lecture 244.Effect of Monoclonal Antibody-mitomycin C Conjugate on Growth of Human Colon Carcinoma Transplanted to Nude Mice / N.Ogata et al. / p397～397
• General Lecture 245.Effects of K-18 against Transplantable Human Cancer in Nude Mouse / K.Nakatani et al. / p397～397
• General Lecture 246.Combination Chemotherapy with FT-207 and Amphotericine B in Advanced Gastric Cancer / S.Akazawa et al. / p398～398
• General Lecture 247.The Effect of Lipopolysaccharide Immobilized Fiber on the Vx2 Tumor of the Rabbits / T.Tani et al. / p398～398
• General Lecture 248.Experimental Studies on Cyclophosphamide Pretreatment in Tumor Cryotherapy / K.Miya et al. / p398～398
• General Lecture 249.Clinical Studies on the Life History of Colo-rectal Adenoma and Cancer / M.Tada et al. / p399～399
• General Lecture 250.Effect of Kallidinogenase on the Proliferation and Metastasis of Carcinoma Cells and Platelet Aggregation / Y.Kawai et al. / p399～399
• General Lecture 251.Homostatic Disorder in Hemopoietic Malignancy / M.Tsuda et al. / p399～399
• General Lecture 252.Microangiopathic Hemolytic Anemia with Disseminated Intravascular Coagulation in Metastatic Carcinoma / R.Takeuchi et al. / p400～400
• General Lecture 253.The Combination Therapy for the Experimental Tumor with Hyperbaric Oxygenation(abb.OHP)and Anti-tumor Antibiotics / H.Sugiyama et al. / p400～400
• General Lecture 254.Effects of Hyperbaric Oxygenation and ACNU in Experimental Bladder Tumor / T.Akiya et al. / p400～400
• General Lecture 255.ACNU Delivery to Malignant Brain Tumor Tissue and Serum--Route of Administration and Effect of Phenobarbital / K.Muraoka et al. / p401～401
• General Lecture 256.Experimental Study on Proliferation Kinetics of Residual Tumor Cells Following Operation for Malignant Tumor / Y.Saitoh et al. / p401～401
• General Lecture 257.Cell Kinetics and Clinical Features of Acute Lymphoblastic Leukemia(ALL)in Children / Y.Kato et al. / p401～401
• General Lecture 258.Clinicostatistical Observation on Renal Cell Carcinoma / O.Yoshizumi et al. / p402～402
• General Lecture 259.Ten Years Operative Results of Renal Carcinoma With Special Reference to Radical Nephrectomy / S.Kumagai et al. / p402～402
• General Lecture 260.Survival of Patients with Transitional Cell Carcinoma Treated by Surgery:Comparative Results of the Old,Mid and Recent Series / T.Saiki et al. / p402～402
• General Lecture 261.Bladder Cancer in Aged Patients / S.Isaka et al. / p403～403
• General Lecture 262.Partial Nephrectomy for Renal Carcinoma:Report of 4 Cases / Y.Tachibana et al. / p403～403
• General Lecture 263.The Treatment of the Superficial Bladder Tumor with Intravesical Chemotherapy after Transurethral Resection / K.Kudoh et al. / p403～403
• General Lecture 264.The Value of Urethrectomy in Patients of Urinary Bladder Cancer / M.Sugimoto et al. / p404～404
• General Lecture 265.Clinico-pathological Studies of Total Cystectomy for Bladder Cancer / J.Satoh et al. / p404～404
• General Lecture 266.Treatment of Renal Cell Carcinoma by Neocarzinostatin(NCS) / K.Tari et al. / p404～404
• General Lecture 267.Chemotherapy of Renal Cell Carcinoma 3. Single-agent Therapy with FT-207 or Vinblastine / Y.Satomi et al. / p405～405
• General Lecture 268.Efficacy of Vinca Alkaloids,Carbazilquinone and Cyclophosphamide Combination Chemotherapy in Patients with a Variety of Malignant Neoplasms / C.Konda et al. / p405～405
• General Lecture 269.CPA-ADR-ACNU Combination Chemotherapy with Autologous Bone Marrow Transplantation in Advanced Solid Tumors / T.Tajima et al. / p405～405
• General Lecture 270.P-VEMPFA Therapy for Head and Neck Malignant Tumor / H.Saito et al. / p406～406
• General Lecture 271.Sequential MTX and 5-FU in the Head and Neck Cancer / M.Horiuchi et al. / p406～406
• General Lecture 272.Chemotherapy of Pulmonary Metastasis of Head and Neck Cancer / J.Tanaka et al. / p406～406
• General Lecture 273.Study on Preoperative Irradiation in the Treatment of Cancer of the Uterine Cervix / M.Hayafuji et al. / p407～407
• General Lecture 274.Intraoperative Radiotherapy for Uterine Cervical Cancer / M.Imachi et al. / p407～407
• General Lecture 275.Relationship between Prognosis and Lymphnode Metastases in Patients with Postoperative Radiotherapy for Carcinoma of the Uterine Cervix / Y.Tanaka et al. / p407～407
• General Lecture 276.Postoperative Radiotherapy for Carcinoma of the Uterine Cervix / Y.Honke et al. / p408～408
• General Lecture 277.The Significance of Tumor Response as a Prognostic Factor during Radiotherapy in Uterine Cervix Cancer / Y.Kikuchi et al. / p408～408
• General Lecture 278.Radiotherapy for Carcinoma of the Uterine Cervix / Y.Takegawa et al. / p408～408
• General Lecture 279.Analysis of Atypical Treatment Method of Intracavitary Irradiation for Carcinoma of the Uterine Cervix / S.Satoh et al. / p409～409
• General Lecture 280.Relationship between Histological Classification and Local Control Rate in the Cases of Carcinoma of the Uterine Cervix, Treated by Fast Neutrons and Photons / S.Morita et al. / p409～409
• General Lecture 281.Pre or Post-operative Radiotherapy for Carcinoma of the Uterine Cervix / Y.Kawamura et al. / p409～409
• General Lecture 282.Three to Four Year Survival Rate of the Carcinoma of the Cervix Uteri Treated with Immuno-,Chemo-,and Radiation Therapy / M.Saito / p410～410
• General Lecture 283.Five Years Follow up Uterine Cervical Carcinomas Treated with Ralstron and Para-aorta Lymphnode Irradiation / A.Murakami et al. / p410～410
• General Lecture 284.Basic and Clinical Study on the Irradiation and Hyperthermia Therapy of Uterine Carcinoma / M.Tsuchida et al. / p410～410
• General Lecture 285.Clinical Evaluation of Serum CEA Levels and Immunoperoxidase Staining for CEA in Uterine Cervix Cancer / K.Takahashi et al. / p411～411
• General Lecture 286.Radiotherapy Combined with Intermittent Administration of Misonidazole and ACNU / H.Asakura et al. / p411～411
• General Lecture 287.Palliative Radiotherapy in the Management of Bone and Brain Metastatic Disease / T.Watari et al. / p411～411
• General Lecture 288.Not Received / /
• General Lecture 289,Radiotherapy for Malignant Solid Tumor in Childhood--Intraoperative Irradiation / N.Ohnuma et al. / p412～412
• General Lecture 290.Afterloading Interstitial Brachytherapy by Ir-192 Seed Assembly for the Malignant Brain Tumor / M.Nishio et al. / p412～412
• General Lecture 291.Evaluation of Preoperative Irradiation for Malignant Brain Tumors / T.Shiina et al. / p412～412
• General Lecture 292.ACNU-induced G₂M Accumulation and Its Significance to the Modification of the in vitro Radiation Response / N.Murakami et al. / p413～413
• General Lecture 293.Radiotherapy for Cancer of the Maxillary Sinus, with Boost Therapy by Low Dose Rate Intracavitary Irradiation / M.Takayama et al. / p413～413
• General Lecture 294.Radiation Therapy of Primary Nasal and Paranasal Sinus Carcinoma / H.Miyashita et al. / p413～413
• General Lecture 295.Fast-Neutron Radiotherapy for Recurrent Osteogenic Sarcoma of the Maxilla / K.Hayasaki et al. / p414～414
• General Lecture 296.Maxillary Sinus Carcinoma / H.Shibuya et al. / p414～414
• General Lecture 297.Recurrence Factors of the Maxillary Cancer after Multimodal Treatment from the View Point of Radiotherapy / N.Fuwa et al. / p414～414
• General Lecture 298.Analysis of Causes of Dead Patients with Treated Tongue Cancer(T₁ and T₂) / E.Takenaka et al. / p415～415
• General Lecture 299.Result of Treatment for T1NO Glottic Carcinoma / Y.Akine et al. / p415～415
• General Lecture 300.Radiotherapy of Laryngeal Cancer / A.Ajimu et al. / p415～415
• General Lecture 301.Radiation Therapy of the Early Glottic Cancer / K.Hayakawa et al. / p416～416
• General Lecture 302.Revaluation of Radiation Therapy for T1NOMO Glottic Carcinoma
• Investigation of the Immobilization Method Using Semi-conductor Dosimeter / M.Chatani et al. / p416～416
• General Lecture 303.Oncologic Emergency Irradiation / Y.Nakashima et al. / p416～416
• General Lecture 304.Radioiodine I-131 Therapy in the Treatment of Pulmonary Metastases from Thyroid Carcinoma / K.Kusakabe et al. / p417～417
• General Lecture 305.Multiple Primary Malignant Neoplasms / T.Okawa et al. / p417～417
• General Lecture 306.Clinical Study on Multiple Primary Malignant Neoplasms / S.Yui et al. / p417～417
• General Lecture 307.Increasing of Primary Multiple Cancer in the Head and Neck Region / Y.Matsumura et al. / p418～418
• General Lecture 308.Multiple Primary Malignancies in Head and Neck Cancer / S.Ebihara et al. / p418～418
• General Lecture 309.Study on the Double Cancer / K.Yao et al. / p418～418
• General Lecture 310.Clinical Studies on Multiple Primary Cancer and Postirradiation Sarcoma / S.Higashi et al. / p419～419
• General Lecture 311.Secondary and Multiple Cancers after Radiotherapy for Cancer of the Oral Region / J.Horiuchi et al. / p419～419
• General Lecture 312.Double Cancer of Esophagus and Other Organ--A Study of 60 Cases / H.Amano et al. / p419～419
• General Lecture 313.Analysis of Patients with Multiple Primary Cancers in the Sphere of Gastroenterological Surgery--Especially Sequential Cancer Lesion after Treatment for Primary Lesion / H.Nishidoi et al. / p420～420
• General Lecture 314.Study on 116 Cases of Gastric Cancer Complicated by Cancer of Other Organs / H.Suzuki et al. / p420～420
• General Lecture 315.Statistical Studies on the Cases with Gastric Cancer Combined with Cancer in Other Organs:445 Cases out of 66 Hospitals in Japan / K.Yoshino et al. / p420～420
• General Lecture 316.Clinical Report of an Over 21 Years Successfully Treated and Survived Case with Oral Multiple Cancers and Early Gastric Cancer / K.Todaka et al. / p421～421
• General Lecture 317.A Clinical Study on Multiple Cancers of Colon and Rectum / T.Shimizu et al. / p421～421
• General Lecture 318.Detection of Second Primary Cancer in a Screening Program of Stage I Lung Cancer Patients after Resection / K.Iuchi et al. / p421～421
• General Lecture 319.Four Cases Reports of Sarcoma Combined with Carcinoma / Y.Ubayama et al. / p422～422
• General Lecture 320.Thirty-four Cases of Hematological Malignancies Associated with Solid Tumors / N.Horikoshi et al. / p422～422
• General Lecture 321.Second Malignancies in Non-Hodgkin's Lymphoma / K.Sakai et al. / p422～422
• General Lecture 322.Two Patients with Triple Cancers in the Breast Cancer / H.Abe et al. / p423～423
• General Lecture 323.Multiple Primary Carcinomas of the Uterus and Radiation-induced Carcinomas / J.Ishii et al. / p423～423
• General Lecture 324.Late Development of Sarcoma in the Radiation Field Following Treatment of Cervical Cancer / R.Tsunematsu et al. / p423～423
• General Lecture 325.Double Primary Carcinoma of the Vulva and Cervix / I.Tsukiyama et al. / p424～424
• General Lecture 326.Effect of Mitoxantrone against Primary and Recurrent Breast Cancer / T.Tsukui et al. / p424～424
• General Lecture 327.Chemotherapy against Hepatocellular Carcinoma(HC)in vitro.(Second Report)--Comparison of Anticancer Effect between Daunomycin(DAM)and Conjugated DAM with Antibodies to Human α-Fetoprotein(CONJ) / K.Kukita et al. / p424～424
• General Lecture 328.Treatment of Hepatoma with Conjugate of Adriamycin and Anti-a-fetoprotein Anti-body / Y.Une et al. / p425～425
• General Lecture 329.A Combined Effect of Adriamycin and Hyperthermia on Cellular Uptake of ³H-Thymidine in Ehrlich Ascites Tumor Cells in vitro / K.Naito et al. / p425～425
• General Lecture 330.An Aspect of the Intravenous Drop Infusion of Adriacin(Part 2) / H.Masuda et al. / p425～425
• General Lecture 331.Phase II & Preliminary Phase III Clinical Trials of 4'-O-tetrahydropyranyladriamycin(THP-ADM)for Hematopoietic Malignancies / Y.Fujiwara et al. / p426～426
• General Lecture 332.Clinical and Experimental Studies on THP-adriamycin for Breast Cancer / K.Fujiwara et al. / p426～426
• General Lecture 333.Clinical Study of 4'-O-Tetrahydropyranyl Adriamycin (THP) / H.Majima et al. / p426～426
• General Lecture 334.Intravesical Therapy with 4'-epi-Adriamycin in Patients with Superficial Bladder Tumors / T.Tsushima et al. / p427～427
• General Lecture 335.Effects of Aclacinomycin A on Urogenital Malignancies / S.Noguchi et al. / p427～427
• General Lecture 336.Chemotherapy of Malignant Ovarian Tumors / N.Ohhama et al. / p427～427
• General Lecture 337.Non-invasive Cardiac Evaluation of Patients Receiving Anthracycline / I.Maekawa et al. / p428～428
• General Lecture 338.Protective Effect of Coenzyme Q in Cardiotoxicity of Adriamycin / K.Okuma et al. / p428～428
• General Lecture 339.Protective Effect of Coenzyme Q₁₀ on Chronic Adriamycin Cardiomyopathy / Y.Uekita et al. / p428～428
• General Lecture 340.Prevention of Adriamycin-related Alopecia with Scalp Cooling / Y.Kidera et al. / p429～429
• General Lecture 341.Clinical Response with Cis-diammine-dichloro Platinum in Esophageal Cancer / T.Sasaki et al. / p429～429
• General Lecture 342.A Combination Chemotherapy of Cis-Dichlorodiammineplatinum(II)(CDDP)and Bleomycin(BLM)in Advanced Esophageal Carcinoma / M.Hayakawa et al. / p429～429
• General Lecture 343.Combination Chemotherapy of CDDP in Esophageal Cancer Patients / T.Yoshihara et al. / p430～430
• General Lecture 344.Cis-Dichlorodiaminneplatinum(II)in Treatment of Esophageal Carcinoma / Y.Murata et al. / p430～430
• General Lecture 345.Intraarterial Infusion Therapy with CDDP for Liver Tumor / M.Miyagiwa et al. / p430～430
• General Lecture 346.Clinical and Pathological Studies of a Case of Recurrent Fallopian Tubal Carcinoma with Cisplatin Therapy / K.Fujinawa et al. / p431～431
• General Lecture 347.Not Received / /
• General Lecture 348.CDDP-ACR Combination Chemotherapy for Malignant Ovarian Tumors / T.Jobo et al. / p431～431
• General Lecture 349.Combination Chemotherapy of Primary Ovarian Cancer with Cis-platinum,Aclacli-nomycin A and FT-207 / T.Tase et al. / p431～431
• General Lecture 350.Cisplatin and PAC (Cisplatin,Adriamycin,Cyclophosphamide)Chemotherapy for Advanced Ovarian Carcinomas / M.Yamasaki et al. / p432～432
• General Lecture 351.Chemotherapy of Gynecological Malignancies with Cisplatin Combination Therapy / K.Takakuwa et al. / p432～432
• General Lecture 352.Studies on Preoperative Chemotherapy for Advanced Ovarian Cancer with Cisplatin / S.Izumi et al. / p432～432
• General Lecture 353.Intrapleural and Intraperitoneal Administration of Cis-platinum Combined with In-travenous Injection of Sodium Thiosulphate--Two Channel Chemotherapy-for 4 Ovarian Carcinomas and 3 Other Gynecological Malignancies / M.Hatae / p433～433
• General Lecture 354.The Effects of Cisplatin on Malignant Ovarian Tumors were Studied Prospectively / Y.Nishida et al. / p433～433
• General Lecture 355.Chemotherapy of Advanced Epitherial Ovarian Cancer with Combination of Cisplatin(P),Adriamycin(A),and Cyclophosphamide(C) / R.Tsunematsu et al. / p433～433
• General Lecture 356.The Role of Cisplatin in the Treatment of Advanced Gynecological Malignancies / K.Hirabayashi et al. / p434～434
• General Lecture 357.Cis-platinum,Vinblastine,Bleomycin-Chemotherapy for Uterine Cervical Carcinomas / K.Ueda et al. / p434～434
• General Lecture 358.Cis-Platinum,Adriamycin and Cyclophosphamide Therapy for Brain Metastasis of Tubal Carcinoma / M.Ikeuchi et al. / p434～434
• General Lecture 359.Antitumor Activity of Cisplatin against Malignant Brain Tumors / K.Kato et al. / p435～435
• General Lecture 360.A Combination Chemotherapy with Cis-Platinum,Vincristine,and Peplomycin for Squamous Cell Carcinoma / Y.Araki et al. / p435～435
• General Lecture 361.The Effect of Cisplatin to the Head and Neck Cancer / T.Sonoda et al. / p435～435
• General Lecture 362.Protective Effect of Fosfomycin from Cis-platinum-induced Nephrotoxicity in Head and Neck Cancer Patients / K.Tanaka et al. / p436～436
• General Lecture 363.Clinical Study of Combination Chemotherapies for Recurrent Head and Neck Cancer with Cis-Diamminedichloroplatinum(CDDP),BLM and MTX(Regimen 1),as well as with CDDP and Pepleomycin(Regimen 2) / A.Noguchi et al. / p436～436
• General Lecture 364.CAP Therapy in Hormone Refractory Prostatic Cancer / M.Sasaki et al. / p436～436
• General Lecture 365.Favorable Effect of Preoperative Multi-drug Chemotherapy and Radiation Therapy in Children with Disseminated Embryonal Cell Carcinoma / S.Ishizone et al. / p437～437
• General Lecture 366.High Dose Cisplatinum Therapy of Malignant Neurogenic Tumors in Children / A.Nakagawara et al. / p437～437
• General Lecture 367.Therapy of Neuroblastoma with Combination Chemotherapy Including Cis-platin / F.Bessho et al. / p437～437
• General Lecture 368.A Clinical Study of Cis-DDP Induced Nephrotoxicity in the Patients with Advanced Urogenital Malignancies / K.Suzuki et al. / p438～438
• General Lecture 369.Antiemetic Effect of Beta-methazone with Droperidol--Compared with High Dose of Beta-methazone and Half Dose of Beta-methazone with Droperidol in Chemotherapy-induced Emesis and Neusea / K.Min et al. / p438～438
• General Lecture 370.Influence of Methylprednisolone on Antitumor Effect of CDDP / K.Lee et al. / p438～438
• General Lecture 371.Management of the Cancer Drug Emesis--How to Control the Emesis Associated with Platinum / M.Nakanami et al. / p439～439
• General Lecture 372.Review of Intra-Arterial Infusion-Radiation Therapy for Lingual Cancer / Y.Nomura et al. / p439～439
• General Lecture 373.Intraarterial Chemotherapy for the Head and Neck Cancer / N.Kohno et al. / p439～439
• General Lecture 374.Clinical and Histological Evaluation of Effects of Intra-Arterial Infusion Chemotherapy for the Patients with Primary Advanced Breast Cancer / K.Toda et al. / p440～440
• General Lecture 375.Effect of Intra-arterial Infusion of Adriamycin on Locally Advanced Primary Breast Cancer(No.2) / K.Sakai et al. / p440～440
• General Lecture 376.Balloon Occuluded Hepatic Infusion of Vindesine (BOHI of VDS)for Liver Metastasis in Refractory Breast Cancer / T.Tabei et al. / p440～440
• General Lecture 377.Intraarterial Infusion Chemotherapy for Locally Advanced and Recurrent Breast Cancer / H.Iwasaki et al. / p441～441
• General Lecture 378.The Evaluation of Preoperative One Shot Bronchial Artery Infusion to the Primary Bronchogenic Carcinoma--Analysing the Influence to the Survival / Y.Lee et al. / p441～441
• General Lecture 379.Results of Several Modifications of Continuous Intra-arterial Infusion Therapy for Metastatic Tumor of Liver from Gastrointestinal Cancers / K.Okuyama et al. / p441～441
• General Lecture 380.Combination Chemotherapy against Inoperable Liver Cancer (3rd Report) -study on the MQ-F-OK Therapy Including Intraarterial Administration of MMC and CQ,and the Background Factors / K.Tsushima et al. / p442～442
• General Lecture 381.Therapy of Metastatic Liver Tumors / A.Narihiro et al. / p442～442
• General Lecture 382.A Histologic Study of the Forepart of Infiltrating Cervical Cancer Subjected to Preoperative Continuous Arterial Infusion Chemotherapy / A.Utsunomiya et al. / p442～442
• General Lecture 383.Clinical Effectiveness of Surgical Chemotherapy on Advanced Uterinecervical Cancer / M.Iwasaki et al. / p443～443
• General Lecture 384.Limitation of Long-term Intra-arterial Infusion Chemotherapy for Bladder Cancer / S.Kanoh et al. / p443～443
• General Lecture 385.Significance of CDDP One-shot Intraarterial Infusion Therapy in Bladder Cancer / Y.Kubota et al. / p443～443
• General Lecture 386.Intra-arterial Infusion for Pelvic Cancers / M.Kita et al. / p444～444
• General Lecture 387.Intra-Arterial Infusion Chemotherapy in the Treatment for Soft Tissue Sarcomas of the Limbs / Y.Beppu et al. / p444～444
• General Lecture 388.Long Term Follow-up Result of Pre-operative Intra-arterial Infusion Treatment for Malignant Bone and Soft Tissue Tumor of Extremities / M.Tsuneda et al. / p444～444
• General Lecture 389.Local Therapy of the Breast Cancer by Adriamycin Ointment / S.Shimizu et al. / p445～445
• General Lecture 390.Successful Treatment of Skin Cancer and Leukoplakia Using 5-FU Salve(5-FUS)and 5-FU Paste(5-FUP)Manufactured for Trial / S.Ishibashi et al. / p445～445
• General Lecture 391.Slow Released Anticancer Agent Prepared by Combination of 5-Fluorouracil and Poly-glycolic Acid / M.Hirano et al. / p445～445
• General Lecture 392.The Effect of Angiotensin II on the Tissue Distribution of Liposomes: Experimental Study / H.Shimizu et al. / p446～446
• General Lecture 393.Studies on the Mechanism of Cytotoxic Effect of 5-Fluorouracil Different Effect for the Concentration of 5-Fu in vitro / K.Naito et al. / p446～446
• General Lecture 394.Comparative Study of the Metabolism of Fluorinated Pyrimidines,5-FUR and 5-FUdR,in Human Tissues / M.Uchida et al. / p446～446
• General Lecture 395.A Study on the Concentration of 5FU Derivatives(THFU)in the Plasma and the Cancer Tissue after Its Oral Administration / T.Ohno et al. / p447～447
• General Lecture 396.Preoperative Chemotherapy for Gastric Cancer by Dripping Intravenous Infusion of FT-207 I. Analysis of 5-FU Concentrations in Sera and Tissues / H.Kikuchi et al. / p447～447
• General Lecture 397.Investigation of Serum Assay of 5-FU through 5-FU and FT-207 Intravenous Con-tinuous Infusion / T.Kato et al. / p447～447
• General Lecture 398.A Study on Preoperative Chemotherapy with Tegafur in Cervical Cancer / T.Kanda et al. / p448～448
• General Lecture 399.Prophylactic Long-term Treatment of Bladder Tumors with Oral Chemotherapy by Tegafur / I.Higa et al. / p448～448
• General Lecture 400.Clinical Experience with SF-SP A New Type Capsule Preparation of Tegafur / K.Ri et al. / p448～448
• General Lecture 401.Comparative Study on Two Different Internal Drugs of Tegafur for Recurrent Breast Cancer / T.Taguchi et al. / p449～449
• General Lecture 402.Phase II Study on SF-SP (Orally Administrated Spansule Tegafur) / T.Taguchi et al. / p449～449
• General Lecture 403.Histological Evaluation on the Effect of Preoperative Intrarectal Administration of 5-FU Emulsion for Rectal Cancer / H.Takatori et al. / p449～449
• General Lecture 404.Studies on Prophylactic Treatment with 5 FU Dry Syrup and Ftoraful Suppository for the Relapse of Bladder Cancer / I.Kondo et al. / p450～450
• General Lecture 405.Pre-& Post-operative Administration of FT-207 Suppositories for Adjuvant Chemotherapy of Colorectal Cancer / K.Ueno et al. / p450～450
• General Lecture 406.Experimental and Clinical Evaluation of Tegafur Suppository and Glutation for Walker 256 Carcinoma and Gastrocolonic Cancer as Preoperative Adjuvant Chemotherapy / M.Kitajima et al. / p450～450
• General Lecture 407.Clinical Application of Tegafur Suppositories for Bladder Tumor / T.Mishina et al. / p451～451
• General Lecture 408.Fundamental and Clinical Studies on Tissue Distribution of UFT / S.Arima et al. / p451～451
• General Lecture 409.Study on the Concentration of Serum and Tumor in Advanced Stomach Cancer after the Oral Administration of UFT / T.Takeshita et al. / p451～451
• General Lecture 410.Comparison between Blood and Lymphatic Transport of UFT and Tegafur / H.Hanaue et al. / p452～452
• General Lecture 411.In situ Activation Mechanisms of Anticancer Agents(Masked Compounds)and Cancer Chemotherapy / Y.Yoshida et al. / p452～452
• General Lecture 412.Methods in Evaluating Histologic Effects of Oral Administration of Tegafur and UFT in Gastric Cancers / J.Fujimoto / p452～452
• General Lecture 413.Concentration of 1-Hexylcarbamoyl-5-fluorouracil(HCFU)and 5-Fluorouracil(FU)in Various Tissues from Rats and from Patients with Colon Cancers / T.Kosaka et al. / p453～453
• General Lecture 414.Clinical Evaluation of 1-hexylcarbamoyl-5-fluorouracil(HCFU)in Hepatocellular Carcinoma / K.Shiraishi et al. / p453～453
• General Lecture 415.A Clinical Trial of Carmoful(HCFU)in the Treatment of Ovarian Carcinoma / T.Noda et al. / p453～453
• General Lecture 416.Study on the Side Effects of Postoperatively Administered HCFU(MIFROL) / H.Izumi et al. / p454～454
• General Lecture 417.Clinical Study of 5'-DFUR / K.Hasegawa et al. / p454～454
• General Lecture 418.Effects of 5'-DFUR on Patients with Gastric,Colorectal and Breast Cancer / T.Tominaga et al. / p454～454
• General Lecture 419.Studies on Hormone Dependency of Thyroid Carcinomas / M.Miyakawa et al. / p455～455
• General Lecture 420.Estrogen Receptors in Gastrointestinal Cancers / Y.Sato et al. / p455～455
• General Lecture 421.Estrogen and Progesterone Receptor of the Stomach Cancer / M.Hori et al. / p455～455
• General Lecture 422.Hormone Receptors in Human Breast Cancer / H.Sonoo et al. / p456～456
• General Lecture 423.Relationship between Hormone Receptors in Human Breast Cancer and Nuclear Grade / T.Nishi et al. / p456～456
• General Lecture 424.Hormonal Profiles and Structures in Normal Women and in Patients with Benign and Malignant Breast Diseases / E.Imayoshi et al. / p456～456
• General Lecture 425.Patients with Prostatic Cancer and Thrombosis during Estrogen Therapy (On Significance of Measurement of Antithrombin III Activity) / T.Tochigi et al. / p457～457
• General Lecture 426.Histological Study on the Relationship between Hyperplasia and Corpus Carcinoma / H.Sakahira et al. / p457～457
• General Lecture 427.Gestagen Therapy in Hyperplasia and Adenocarcinoma of the Endometrium / T.Fukui et al. / p457～457
• General Lecture 428.Variation of Cell Kinetics in Endometrial Cancers and Hyperplasias during Progestogen Treatment / A.Yoshizaki et al. / p458～458
• General Lecture 429.Mitogenic Effect of Progesterone on DMBA-induced Rat Ovarian Cancer--An Experimental Hormone Therapy / N.Kamura et al. / p458～458
• General Lecture 430.The Cell Kinetics of Endometrial Carcinomas Administered High Dose and Long Term of Sex Steroid Hormones / Y.Matsui et al. / p458～458
• General Lecture 431.In vitro Hormon Sensitivity Test with Cultured Human Tumor Cell / H.Ohkura et al. / p459～459
• General Lecture 432.Changes of Estrogen Receptor before and after Chemo-endocrine Therapy for DMBA Induced Rat Mammary Carcinomas / Z.Iwasa et al. / p459～459
• General Lecture 433.Adjuvant Endocrine Therapy on Breast Cancer with Many Axillary Node Metastases / M.Yoshida et al. / p459～459
• General Lecture 434.Long-term Follow-up Result of Transsphenoidal Surgical Hypophysectomy for Disseminated Breast Cancer / Y.Higashi et al. / p460～460
• General Lecture 435.The Usefulness of Ovarian Function Extinguishing Effect in the Postoperative Adjuvant Chemotherapy for Breast Cancer / K.Morimoto et al. / p460～460
• General Lecture 436.Comparison of Serially Detected Serum PA Values and Clinical Course of Patients with Prostate Cancer Treated with Anti-androgen Therapy : A Study in Americans / M.Kuriyama et al. / p460～460
• General Lecture 437.Observation of Serum Immunosuppressive Acidic Protein(IAP)Level in Treatment--Process of Head and Neck Cancer Patients / H.Saito et al. / p461～461
• General Lecture 438.Changes of Serum Concentrations of Immunosuppressive Acidic Protein(IAP)and Glycoproteins, and Skin Tests in Patients with Gastric Cancer before and after Operation / K.Morita et al. / p461～461
• General Lecture 439.Immunosuppressive Acidic Protein in Patients with Intracranial Tumors / N.Murakami et al. / p461～461
• General Lecture 440.Measurement of Immunosuppressive Acid Protein(IAP)and Its Clinical Implication / H.Suzuki et al. / p462～462
• General Lecture 441.IAP and Ferritin in Patients with Urogenital Cancers / Y.Nasu et al. / p462～462
• General Lecture 442.Acid Soluble Proteins(ASP)in Cancer Patients / M.Tan et al. / p462～462
• General Lecture 443.Clinical Study on Serum Immunosuppressive Substance(IS)in Lung Cancer Patients / T.Sakai et al. / p463～463
• General Lecture 444.Evaluation of Serum α₂-globulin Levels in Head and Neck Cancer Patients / M.Miyata et al. / p463～463
• General Lecture 445.Clinical Investigation of Testicular Tumors for Serum LDH / T.Sugawara et al. / p463～463
• General Lecture 446.Evaluation of Tumor Marker for Renal Cancer / K.Takahashi et al. / p464～464
• General Lecture 447.Measurement of Serum Prostatic Acid Phosphatase in Patient with Prostatic Carcinoma--Comparative Study of Radioimmunoassay vs Enzyme Assay / T.Arakawa et al. / p464～464
• General Lecture 448.Pregnancy Associated α2-Glycoprotein(α2-PAG)in Urogenital Malignancies / T.Misaki et al. / p464～464
• General Lecture 449.Cellular Retinol-Binding Protein in Human Squamous Cell Carcinomas of the Head and Neck Region / T.Yanagita et al. / p465～465
• General Lecture 450.A New Simple Enzymatic Assay Method for Urinary Polyamines / T.Yagishita et al. / p465～465
• General Lecture 451.A Study on Antitumor Effects of Polyamine Biosynthesis Inhibitors for Human Cancer Therapy / R.D.Shrestha et al. / p465～465
• General Lecture 452.Alteration of Affinity to Lectins of α₁-Antichymotrypsin in the Patients with Malignant Diseases / H.Kidani et al. / p466～466
• General Lecture 453.Analysis of Elevating Factors in Serum Lipid-bound Sialic Acid(LSA)Level / Y.Uehara et al. / p466～466
• General Lecture 454.A Role of the Measurement of the Serum Sialic Acid Levels in the Cancer Chemotherapy / I.Nakazawa / p466～466
• General Lecture 455.Urinary 6-Hydroxymethylpterin Levels in Patients with Solid Tumor / S.Umemoto et al. / p467～467
• General Lecture 456.Clinical Significance of Urinary 6-hydroxymethylpterin in Cancerous Patients / S.Tsukioka et al. / p467～467
• General Lecture 457.Diagnostic Value of Urinary Hydroxyproline for Bone Metastasis from Uterine Cervical Cancer / T.Arai et al. / p467～467
• General Lecture 458.A Study on the Patients(pts)with Carcinoma(ca),Whose Diagnosis of Primary Organ at Operation Were Different from Those at Autopsy--Analysis of Cellular Proteins with 2-dimensional Gel Electrophoresis / S.Sadahiro et al. / p468～468
• General Lecture 459.Clinical Evaluation of a Thyroxine-Binding Globulin as a Marker of Liver Tumors / S.Terui et al. / p468～468
• General Lecture 460.Clinical Evaluation of Serum Ferritin-Iron Ratio in Uterine Cervix Cancer with Radiotherapy / S.Nishino et al. / p468～468
• General Lecture 461.C-terminal Peptide of Type I Procollagen in the Serum as a Tumor Marker of the Schirrhus Gastric Cancer / K.Koda et al. / p469～469
• General Lecture 462.PNP(Purine Nucleoside Phosphorylase)Activity of Regional Lymphnode Lymphocyte in Patients with Gastric Cancer / T.Kobori et al. / p469～469
• General Lecture 463.Clinical Significance of the Phosphofructokinase(PFK)-Suppressor in the Sera from the Patients with Gastrointestinal Carcinomas / T.Kitsuta et al. / p469～469
• General Lecture 464.Thymidine Kinase Isozyme in Colon Cancer / K.Tsukada et al. / p470～470
• General Lecture 465.Diagnosis of Primary and Secondary Hepatoma with 5'-Nucleotide Phosphodiesterase(5'-NPD)Isozyme Test / H.Ogiwara et al. / p470～470
• General Lecture 466.The Investigations of the Tongue Cancer Treated by Surgery Alone / W.Ohyama et al. / p470～470
• General Lecture 467.Post-surgical Course of Hemiglossectomy Cases without Reconstruction / S.Makino et al. / p471～471
• General Lecture 468.An Evaluation of Neck Dissection in Carcinoma of the Tongue / B.Satake et al. / p471～471
• General Lecture 469.Partial Pharyngolaryngectomy for Pyriform Sinus Cancer / S.Takemiya et al. / p471～471
• General Lecture 470.The Ligation of the Carotid Artery in Head and Neck Cancer / T.Yabe et al. / p472～472
• General Lecture 471.Closure of Head and Neck Defects with Free Forearm Flap / T.Takato et al. / p472～472
• General Lecture 472.Reconstruction of Cervical Esophagus and Oral Cavity by Microsurgical Transfer of Small Intestine / T.Harashina et al. / p472～472
• General Lecture 473.Resection of Thyroid Carcinoma Invading the Trachea / T.Ishihara et al. / p473～473
• General Lecture 474.A Clinicopathological Study of Recurrent Pattern of Primary Liver Cell Carcinoma(PLC) / T.Kusano et al. / p473～473
• General Lecture 475.Diagnosis and Treatment of Cholangiocarcinoma / H.Yamase et al. / p473～473
• General Lecture 476.Hepatocellular Carcinoma Recurring after Hepatic Resection / S.Imaoka et al. / p474～474
• General Lecture 477.Diagnosis and Operation for Locally Recurrent Rectal Cancer / H.Takagi et al. / p474～474
• General Lecture 478.A Newly-developed Pancreaticoduodenectomy / H.Katoh et al. / p474～474
• General Lecture 479.Right Hemicolectomy, Approach from Root of Mesenterium / M.Furusawa et al. / p475～475
• General Lecture 480.Significance of Hepatic and Pulmonary Resection for Metastasis from Colorectal Cancer / T.Ikeda et al. / p475～475
• General Lecture 481.Surgical Management of Pelvic Tumors / S.Osaka et al. / p475～475
• General Lecture 482.Massive Segmental Bone Grafting after Wide en bloc Resection of Malignant Bone Tumors / S.Masuda et al. / p476～476
• General Lecture 483.Clinicopathological Study of 197 Cases of Early Gastric Cancer / H.Hirakawa et al. / p476～476
• General Lecture 484.Recurrence after Radical Surgery for Gastric Carcinoma--Eight Cases Who Died Eight or More Years after Surgery / T.Ichikawa et al. / p476～476
• General Lecture 485.End Results of Geriatric Patients with Gastric Cancer / E.Yamane et al. / p477～477
• General Lecture 486.Gastric Cancers of Young Adults Aged 34 or Below / H.Furukawa et al. / p477～477
• General Lecture 487.Cases of Long Term Survivors in Advanced Gastric Cancer, Borrmann 4 Type / K.Hayakawa et al. / p477～477
• General Lecture 488.Progress of Linitis Platica Type of Gastric Carcinoma and Operative Results--Analysis by Preoperative Roentgenography / H.Nomura et al. / p478～478
• General Lecture 489.A Study on the Relationship between the Prognosis and Clinicopathologic Findings and Treatments of Stage IV Gastric Cancer / T.Nakamura et al. / p478～478
• General Lecture 490.Randomized Study on the Long-term Adjuvant Chemotherapy with Futraful and Mitomycin C for Gastric Cancer
• Second Study(A Third Report) / T.Muto et al. / p478～478
• General Lecture 491.Randomized Clinical Trial of Adjuvant Chemotherapy with CPA Curatively Resected Patients with Stomach Cancer / H.Nakazato et al. / p479～479
• General Lecture 492.A Sequential Chemotherapy Using Mitomycin C and Tegafur in the Treatment of Gastric Cancer after Gastrectomy I.Patient Characteristics and Safety of Regimens / K.Koizumi et al. / p479～479
• General Lecture 493.Intraperitoneal Administration of Anticancer Drug for Gastric Cancer with Serosal Invasion(First Report) / Y.Ohmori et al. / p479～479
• General Lecture 494.Data-base Evaluation of Non-randomized Adjuvant Chemotherapy for Gastric Cancer / T.Nakajima et al. / p480～480
• General Lecture 495.Evaluation of Postoperative Adjuvant Chemotherapy for Gastric Cancer Based on the Relative Hazard Rate / M.Kikuchi et al. / p480～480
• General Lecture 496.Not Received / /
• General Lecture 497.Practice of UFTM Chemotherapy for Borrmann Type 4 Gastric Cancer / H.Iwase et al. / p480～480
• General Lecture 498.Chemotherapy Effect of UFT Enhanced by MMC against Far Advanced Gastric Cancer / S.Yoshida et al. / p481～481
• General Lecture 499.Study on the MFVC-OK Therapy against Inoperable Gastric Cancer, Especially with Poorly Type(6th Report) / Y.Sakata et al. / p481～481
• General Lecture 500.AMUFT(Doxorubicin, Mitomycin C, and UFT)Regimen for Advanced Gastric Cancer / M.Murakami et al. / p481～481
• General Lecture 501.The Study of the Prolongation of Survival Period by Cancer Chemotherapy on Gastric Carcinoma in the Terminal Stage / Y.Inoue et al. / p482～482
• General Lecture 502.A Combination Chemotherapy with ACNU or Adriamycin and 5-FU for End Stage Gastric Cancer / Y.Rai et al. / p482～482
• General Lecture 503.Combination Immuno-Chemotherapy of Inoperable Gastric Cancer with ACNU, 5-fluorouracil and OK432(II) / M.Fujii et al. / p482～482
• General Lecture 504.Combined Modality Therapy of Metastatic Hepatic Disease / S.Kitagawa et al. / p483～483
• General Lecture 505.Postoperative Chemotherapy for the Pancreas Carcinoma / H.Oohigashi et al. / p483～483
• General Lecture 506.Clinical Studies on the Administration of Neocarzinostatin (NCS) for Advanced and Recurrent Carcinoma of the Pancreas / Y.Kunii et al. / p483～483
• General Lecture 507.MFP Therapy for Peritonitis Carcinomatosa / T.Nakagawa et al. / p484～484
• General Lecture 508.Prophylactic Intravesical Instillation Therapy with Adriamycin(ADM)and Mitomycin C(MMC)in Patients with Superficial Bladder Cancer / Y.Ozaki et al. / p484～484
• General Lecture 509.Early Prophylactic, Low Dose and Continuous Intravesical Irrigation Therapy after TUR in Superficial Bladder Tumors / T.Uchida et al. / p484～484
• General Lecture 510.Development and Clinical Application of ACF Regimen / T.Kobayashi et al. / p485～485
• General Lecture 511.Postoperative Prognosis of 163 Lung Cancer Patients with Clinical Stage I Disease / S.Fukai et al. / p485～485
• General Lecture 512.Lung Cancer in Young Persons / H.Ayabe et al. / p485～485
• General Lecture 513.Results of Absolute Non-curative Resection for Colorectal Carcinoma / T.Sekine et al. / p486～486
• General Lecture 514.Prognosis of Resected Sigmoid Colon Cancer Related to Clinico-pathological Findings and Operative Procedures / A.Ouchi et al. / p486～486
• General Lecture 515.Cases of Malignant Tumors of the Biliary Tract / T.Tamio et al. / p486～486
• General Lecture 516.Late Effects of Anticancer Treatment on Long Term Survivors with Pediatric Malignancies / S.Shimizu et al. / p487～487
• General Lecture 517.Malignant Lymphoma in Childhood
• From the Surgical Point of View / K.Shibata et al. / p487～487
• General Lecture 518.Cell Kinetics of Metastatic C 1300 Murine Neuroblastoma Cell after Cyclophosphamide Administration / H.Sakatoku et al. / p487～487
• General Lecture 519.Experimental and Clinical Studies on Adjuvant Therapy for Advanced Neuroblastoma / E.Arima et al. / p488～488
• General Lecture 520.Results of Multidisciplinary Treatment for Maxillary Antrum Cancer / T.Teshima et al. / p488～488
• General Lecture 521.Patterns of Relapse and Prognostic Factors of Squamous Cell Carcinoma of the Maxillary Sinus / M.Kondo et al. / p488～488
• General Lecture 522.The Therapy for Recurrent and Metastatic Cases of Head and Neck Cancer / T.Honda et al. / p489～489
• General Lecture 523.Some Considerations in the Progress of Laryngeal Carcinoma--Relationship of Duration of Hoarseness and Tumor Growth / S.Matsuura et al. / p489～489
• General Lecture 524.Treatment of Anaplastic Carcinoma of the Thyroid Gland / M.Izukura et al. / p489～489
• General Lecture 525.Factors Affecting the Prognosis of Papillary Carcinoma of the Thyroid / M.Hodo et al. / p490～490
• General Lecture 526.Patterns of Relapse of Non-Hodgkin Lymphoma of the Waldeyer's Ring / M.Kondo et al. / p490～490
• General Lecture 527.Mode of Recurrence and Prognosis on Non-Hodgkin's Lymphoma of Waldeyer's Ring / T.Takenaka et al. / p490～490
• General Lecture 528.Survival and Factors Related to the Survival of Recurrent Breast Cancer Patients--A Study with Quantification Theory / Y.Murayama et al. / p491～491
• General Lecture 529.Studies on Breast Cancer with Redness and/or Edema of the Skin / M.Nagino et al. / p491～491
• General Lecture 530.Influence of Pre-operative Biopsy of the Breast Carcinoma on Its Survival Rate / A.Fujiwara et al. / p491～491
• General Lecture 531.Studies of Recurrent Stage I (TNM) Breast Cancer / H.Yamashita et al. / p492～492
• General Lecture 532.Effect of Adjuvant Chemotherapy in Cases of Breast Cancer without Nodal Involvement / S.Miura et al. / p492～492
• General Lecture 533.Breast Cancer with Pleuritis Carcinomatosa / T.Ito et al. / p492～492
• General Lecture 534.Effect of a Possible Target-oriented Anticancer Agent(KM2210,Estradiol-Chlorambu-cil)on Recurrent or Far Advanced Breast Cancer / Z.Yamazaki et al. / p493～493
• General Lecture 535.Response of Recurrent and Metastatic Breast Cancer to Peplomycin / M.Numata et al. / p493～493
• General Lecture 536.Anti-tumor Effect of Peplomycin on Breast Cancer / Y.Hata et al. / p493～493
• General Lecture 537.Clinical Evaluation of Adriamycin for Advanced and Recurrent Breast Cancer (No.3) -A Joint Study by 26 Institutes on the CAF and CMcF Regimens / K.Kubo et al. / p494～494
• General Lecture 538.Hormone-chemotherapy of Pulmonary Metastasis of Breast Cancer with Cyclophospha-mide,Adriamycin,Prednisolone and Tamoxifen(CAPT) / Y.Nakamura et al. / p494～494
• General Lecture 539.Chemo-endocrine Therapy with Tamoxifen,Tegafur and Low-dose Adriamycin for Treatment of Breast Cancer / T.Wada et al. / p494～494
• General Lecture 540.Prospective Randomized Trial of Chemo-endocrine Therapy for Advanced Breast Cancer / H.Tashiro et al. / p495～495
• General Lecture 541.Basic Study on Chemo-endocrine Therapy for Breast Cancer / T.Ikeda et al. / p495～495
• General Lecture 542.Bronchofiberscopic Findings of Intrathoracic Involvement of Malignant Lymphoma / K.Tsunematsu et al. / p495～495
• General Lecture 543.Combination Therapy of Vinca Alkaloids and Nicardipine in Patients with Non-Hodgkin's Lymphoma Who Became Resistant to Various Chemotherapeutic Agents and Relapsed / T.Honda et al. / p496～496
• General Lecture 544.Combination Chemotherapy for Non-Hodgkin's Lymphoma Except for Large Cell Type with Adriamycin,Vincristine,Ifosfamide and Prednisolone(AVIP) / H.Ueoka et al. / p496～496
• General Lecture 545.Combined Chemotherapy for Undifferentiated Small Cell Carcinoma of the Esophagus / K.Taniguchi et al. / p496～496
• General Lecture 546.Treatment of Inoperative Esophageal Cancer by Oral Administration of Oil Bleomycin / J.Tamura et al. / p497～497
• General Lecture 547.Nebulization Chemotherapy in Treatment of Tracheal and Bronchial Carcinomas / T.Tatsumura et al. / p497～497
• General Lecture 548.Evaluation of Therapeutic Effect of MTX with Leucovorin Rescue for Gestational Trophoblastic Disease / H.Uchino et al. / p497～497
• General Lecture 549.High Dose MTX/CF Rescue Therapy in Patients with Hemopoietic Neoplasmas & Solid Tumors / Y.Kobayashi et al. / p498～498
• General Lecture 550.Phase I-II Study of 7-N-(p-hydroxyphenyl)-mitomycin C / S.Meguro et al. / p498～498
• General Lecture 551.Phase II Study of KW-2083 in Patients with Lung Cancer and Metastatic Pulmonary Tumor / T.Shinkai et al. / p498～498
• General Lecture 552.Clinical Studies on NK-171 for Advanced and Recurrent Cancer Patients / K.Yoshinaka et al. / p499～499
• General Lecture 553.VP-16 in Small Cell Carcinoma of the Lung / Y.Kurita et al. / p499～499
• General Lecture 554.Trials of VP-16 Containing Combination Chemotherapy for Advanced Lymphomas Refractory to Combination Chemotherapy / A.Oyama et al. / p499～499
• General Lecture 555.Clinical Appearance of Testis Tumors with Positive Human Chorionic Gonadotropin / T.Kawai et al. / p500～500
• General Lecture 556.Indication and Treatment Result of Testicular Tumors / M.Maruoka et al. / p500～500
• General Lecture 557.Results of Treatment for Pure Seminoma of the Testis / S.Komatsubara et al. / p500～500
• General Lecture 558.Results of Treatment for Non-seminomatous Tumor of Testis / S.Komatsubara et al. / p501～501
• General Lecture 559.Clinical Observation of Prostatic Cancer / H.Morita et al. / p501～501
• General Lecture 560.Factors Affecting Prognosis of Stage D Prostatic Cancer after Endocrine Therapy / T.Masukagami et al. / p501～501
• General Lecture 561.Clinical Investigation of Testicular Tumor / A.Furuhata et al. / p502～502
• General Lecture 562.A Case of Successful Treatment of Advanced Seminoma / K.Hakamata et al. / p502～502
• General Lecture 563.Prognosis of Germ Cell Tumor of the Testis / T.Miyauchi et al. / p502～502
• General Lecture 564.Chemotherapy for Patients with Refractory,Advanced Testicular Tumor / K.Nakamura et al. / p503～503
• General Lecture 565.VM-26 Salvage Therapy for Refractory Testicular Cancers / H.Oda et al. / p503～503
• General Lecture 566.Management of Patients with Stage I Ovarian Cancer / H.Nishimura et al. / p503～503
• General Lecture 567.Management of Stage I Ovarian Cancer / S.Isonishi et al. / p504～504
• General Lecture 568.Clinical and Pathological Analysis on Malignant Ovarian Tumor--Second Look Operation / T.Matsukuma et al. / p504～504
• General Lecture 569.Some Considerations Regarding to Maintain Reproducibility in Patients with Malignant Ovarian Tumors / T.Miyazaki et al. / p504～504
• General Lecture 570.T Lymphocytes Subsets of Patients with Cancer in the Head and Neck / T.Furusaka et al. / p505～505
• General Lecture 571.PHA Lymphocyte Stimulation Test(2nd Report) / K.Ietomi et al. / p505～505
• General Lecture 572.The Effect of Histamine on Blastoid Transformation of Human Lymphocytes / T.Motoki et al. / p505～505
• General Lecture 573.Enhancement of in vitro Lymphocyte Proliferative Response by Vitamin B Compound / T.Toge et al. / p506～506
• General Lecture 574.Evaluation of Fluorescence Polarization of Human Lymphocytes (SCM test)in the Diagnosis of Gynecologic Cancer / T.Tenzaki et al. / p506～506
• General Lecture 575.Study of Indomethacin Sensitive Suppressor Cells against Gastric and Colon Cancer Peripheral Lymphocyte Tumor Extract Reactions / H.Nakanishi et al. / p506～506
• General Lecture 576.Analysis of T-cell Subset Changes in Patients with Malignant Brain Tumors from the Viewpoint of Monoclonal Antibody / S.Yoshida et al. / p507～507
• General Lecture 577.Natural Killer Activity of Regional Lymph Node Cells from Cancer Patient with Gastric Cancer / F.Koba et al. / p507～507
• General Lecture 578.Natural Killer Cell Activity in Patients with Malignant Lymphoma / M.Nishikori et al. / p507～507
• General Lecture 579.Depression of the Generation of Cell-Mediated Cytotoxicity after Surgery in Cancer Patients / S.Miyazaki et al. / p508～508
• General Lecture 580.Activation of Suppressor Macrophage by Serum or Immunosuppressive Substance(ISS)of Patient with Gastric and Colon Cancer / K.Ohnishi et al. / p508～508
• General Lecture 581.ADCC Activity on Patients with Cancer and Influence by Its Treatment / T.Takahashi et al. / p508～508
• General Lecture 582.Evaluation of Immunological Parameters of Gastric Carcinoma / S.Kanabe et al. / p509～509
• General Lecture 583.Follow up Studies of NK Activity and Other Immuno Parameters Patients with Digestive Tract Cancer / T.Beika et al. / p509～509
• General Lecture 584.Estimating Prognosis of the Patients with Advanced Cervical Cancer from Tumor Marker and Immunological Parameter / Y.Matsuura et al. / p509～509
• General Lecture 585.Studies on the Tumor-host Relationship in Oral Cancer 2.Regional Lymph Node Metastasis / S.Miyauchi et al / p510～510
• General Lecture 586.Cellular Immunological Variation Due to the Treatment of Esophageal Carcinoma:Influence of Pre-Operative Irradiation and Operative Stress / Y.Nakata et al. / p510～510
• General Lecture 587.Tumor Immunity in Thyroid Carcinoma:Possibility of Induction of Host's Anti-Tumor Immunological Responses by ¹³¹ I Therapy / A Sugenoya et al. / p510～510
• General Lecture 588.Inactivation of Immunosuppressive Factor in Ascitic Fluid of Patient with Gastro-intestinal Cancer / K.Amemiya et al. / p511～511
• General Lecture 589.Studies of Blood Group Isoantigen Specificity:Carcinoma in situ and Non-Malignant Bladder Lesions / H.Takigawa et al. / p511～511
• General Lecture 590.Not Received / /
• General Lecture 591.Enhancing Effect of Mitomycin C on Hematogeneous Metastases of Ascites Hepatoma in Rat / K.Murasawa / p511～511
• General Lecture 592.The Significance of Administration of Anabolic Steroid on Post-Operative Condition of the Cancer Patients / Y.Ooshika et al. / p512～512
• General Lecture 593.Radiation Treatment of Cancer of the Esophagus / M.Hareyama et al. / p512～512
• General Lecture 594.Combined Therapy of Esophageal Carcinoma / G.Shirozu et al. / p512～512
• General Lecture 595.Radiation Treatment of Esophageal Carcinoma Using High Dose Rate Remote Afterloader / Y.Hishikawa et al. / p513～513
• General Lecture 596.Radiotherapy for Esophageal Carcinomas with Bronchoesophageal Fistula / S.Yamada et al. / p513～513
• General Lecture 597.Histopathologic Effect of Irradiation on Esophageal Cancer / K Nishikawa et al. / p513～513
• General Lecture 598.The Infiltration and Deterrence in the Esophageal Wall of the Upper Gastric Cancer, and the Determination of the Resectional Line for Progressive Upper Gastric Cancer / H.Joko et al. / p514～514
• General Lecture 599.Intraoperative Radiotherapy in Treatment for Gastric Cancer / K.Miwa et al. / p514～514
• General Lecture 600.Preoperative Combined Therapy with Irradiation and Chemotherapy on the Advanced Gastric Cancer in Cardio-esophageal Region / I.Takagi et al. / p514～514
• General Lecture 601.Studies on Resected Gastric Carcinomas Treated with Intra-abdominal Administration of ¹⁹⁸Au Colloid / T.Saito et al. / p515～515
• General Lecture 602.The Role of Irradiation in Multi-disciplinary Treatments of Primary Hepatoma / M.Ryu et al. / p515～515
• General Lecture 603.Significance of Intraluminal Irradiation as a Surgical Adjuvant Therapy for Carcinoma of the Proximal Bile Duct / Y.Abe et al. / p515～515
• General Lecture 604.Experiences of Fast Neutron Irradiation Therapy in Liver and Biliary Tract Cancers / T.Nagashima et al. / p516～516
• General Lecture 605.Survey of X-ray Sensitivity of Human Lung Carcinoma in vitro / S.Okada et al. / p516～516
• General Lecture 606.Multidisciplinary Treatment against Small Cell Lung Cancer / N.Saijo et al. / p516～516
• General Lecture 607.Small-Cell Carcinoma of the Lung:Combined Chemotherapy and Radiation / Y.Takahashi et al. / p517～517
• General Lecture 608.Radiotherapy of Primary Lung Cancer / H.Shirato et al. / p517～517
• General Lecture 609.Radiotherapy for Lung Cancer / T.Sugimoto et al. / p517～517
• General Lecture 610.Evaluation of Once-a-week Single High Dose Irradiation for Lung Cancer / A.Mikami et al. / p518～518
• General Lecture 611.Experimental Radiotherapy of Human Urogenital Malignant Neoplasms Transplantable to Nude Mice / J.Hasegawa et al. / p518～518
• General Lecture 612.Preoperative Irradiation and Radical Cystectomy for Bladder Cancer / M.Miyakawa et al. / p518～518
• General Lecture 613.Role of Preoperative Irradiation of Bladder Carcinoma / T.Kamada et al. / p519～519
• General Lecture 614.Evaluation of Post-operative Irradiation in Breast Cancer / J.Ito et al. / p519～519
• General Lecture 615.Evaluation of Postoperative Radiotherapy by the Moving Strip Technique for Primary Ovarian Cancer / Y.Katsube et al. / p519～519
• General Lecture 616.Ir-192 Remoto Afterloading System for High Dose-rate Intracavitary Irradiation / G.Uchiyama et al. / p520～520
• General Lecture 617.Augmentation of CT-number Enhanced by Angiographin in Tumors Administered Fibrinolytic Agents (UK and LMWD) / T.Ogino et al. / p520～520
• General Lecture 618.Studies on Serum and Lymphocytes Levels of Superoxide Dismutase (SOD) in Human Carcinomas / J.Sato et al. / p520～520
• General Lecture 619.Clinical Radio Protective Anti-inflammatory Effects by Super Oxide Dismutase (Orgo-tein) / T.Kaneda et al. / p521～521
• General Lecture 620.Study on the Radioprotective Effect of Amifostine(YM-08310)with the Double Blind Method / H.Niibe et al. / p521～521
• General Lecture 621.Tumour Kinetics and the Timing of the Second Dose to Obtain a Better Radiocurability of the Tumour / Y.Takaki / p521～521
• General Lecture 622.Comparison of the Effect between an Active Specific Immunotherapy Using the Immune Reaction of a Low-dose Irradiated Tumor Tissue and That Using Irradiated Tumor Cells / Y.Ogawa et al. / p522～522
• General Lecture 623.The Radioprotective Effect of WR-2721 in Head and Neck Tumors / H.Tsujii et al. / p522～522
• General Lecture 624.Plasma Prolactin Levels in Patients with Postoperative Breast Cancer--Effects of Nauzelin on Plasma Prolactin Levels / M.Endow et al. / p522～522
• General Lecture 625.Clinical Evaluation of Nauzelin as an Antiemetic in Patients Receiving Chemotherapy and/or Radiotherapy / K.Sekiguchi et al. / p523～523
• General Lecture 626.Efficacy of Bioclean Room for the Protection from Infection in Treatment of Carcinoma of the Lung / N.Sawamura et al. / p523～523
• General Lecture 627.Tumor Inhibition Effect of Ultrasound--Experimental Study / R.Akimoto et al. / p523～523
• General Lecture 628.Not Received / /
• General Lecture 629.Anti-tumor Effect Induced by Microwave Coagulation for Tumor / H.Noguchi et al. / p524～524
• General Lecture 630.Effect of Coagulation Therapy on Microwave Tissue Coagulator for Malignant Tumor Regarding the Incidence of Metastasis / H.Yamaue et al. / p524～524
• General Lecture 631.Molding Chemoembolization by Fibrin Clot Containing Anticancer Drug / J.Itoh et al. / p524～524
• General Lecture 632.Not Received / /
• General Lecture 633.A Clinical and Experimental Study of the Intermittent Hepatic Artery Occlusion(IHAO)with Infusion Chemotherapy for the Unresectable Hepatocellular Carcinoma(HCC) / A.Naitoh et al. / p525～525
• General Lecture 634.Hepatic Artery Embolization for Metastatic Liver Tumor / K.Ogawa et al. / p525～525
• General Lecture 635.Not Received / /
• General Lecture 636.Ferromagnetic Microembolization in the Treatment of Hepatomas:The Therapeutic Effect on the Daughter Nodules / H.Yuri et al. / p525～525
• General Lecture 637.Transarterial Embolization during the Operation for Hepatoma / K.Hori et al. / p526～526
• General Lecture 638.Effect of Pre-operative TAE on Liver Regeneration in the Rats / O.Takahashi et al. / p526～526
• General Lecture 639.Pathohistological Study Concerning the Resected Hepatocellular Carcinoma Treated with Preoperative Transcatheter Arterial Embolization / T.Sonoyama et al. / p526～526
• General Lecture 640.Studies on Embolotherapy of Lung Cancer / M.Morita et al. / p527～527
• General Lecture 641.Clinical Studies on Transcatheter Embolization of Renal Artery for Renal Cell Carcinoma / K.Yoneda et al. / p527～527
• General Lecture 642.Experience in the Treatment of Renal Carcinoma through Usage of Balloon Catheter / I.Murahashi et al. / p527～527
• General Lecture 643.Balloon-assisted Renal Embolization with Absolute Ethanol / H.Kobayashi et al. / p528～528
• General Lecture 644.Arterial Embolization:Effectiveness and Limitation to the Cancer / Y.Watanabe et al. / p528～528
• General Lecture 645.Side Effect of Hepatic Artery Embolization--Compatible Ivalon and Gelatine Sponge / K.Ido et al. / p528～528
• General Lecture 646.Computed Tomography of the Nasopharyngeal Carcinoma / S.Yamashita et al. / p529～529
• General Lecture 647.Clinical Diagnosis Significance of Computed Tomography in Laryngeal Carcinoma / S.Takeoda et al. / p529～529
• General Lecture 648.Computed Tomography in Carcinoma of Esophagus / T.Fukuda et al. / p529～529
• General Lecture 649.The Use of Computed Tomography(CT)to Evaluate Anterior Mediastinal Tumors / T.Suito et al. / p530～530
• General Lecture 650.The Analysis of the CT Scans of Ovarian Tumors / R.Akiba et al. / p530～530
• General Lecture 651.The Usefullness of Computerized Tomography in Ovarian Cancer Treatment / M.Murae et al. / p530～530
• General Lecture 652.CT Staging of Urinary Bladder Carcinoma / H.Kiyohara et al. / p531～531
• General Lecture 653.The Value of CT Scan in Pelvic Exenteration / T.Hayashi et al. / p531～531
• General Lecture 654.Clinical Application of Nuclear Magnetic Resonance Computed Tomography(NMR-CT)in Prostatic Lesions / T.Hara et al. / p531～531
• General Lecture 655.In vivo NMR Studies on Tumors / S.Naruse et al. / p532～532
• General Lecture 656.Image Diagnosis in the Staging of Urinary Bladder Cancer / A.Iwai et al. / p532～532
• General Lecture 657.Study of Liver Ultrasonography by Selective Arterial Injection of Fat Emulsion / H.Mizutani et al. / p532～532
• General Lecture 658.The Use of Sonolaproscope in Diagnosis of Hepatocellular Carcinoma / K.Hirata et al. / p533～533
• General Lecture 659.Differential Diagnosis of Ovarian Tumors Images and Biochemical Parameters / S.Katashima et al. / p533～533
• General Lecture 660.Diagnostic Study on Malignant Ovarian Tumors by Ultrasonography / M.Akamine et al. / p533～533
• General Lecture 661.Applicability of Transurethral Intravesical Radial Scan Ultrasonography(RSUSG)for Estimating the Urinary Bladder Invasion of Cervical Cancer / M.Nishi et al. / p534～534
• General Lecture 662.Significance of 67Ga and 201T1 Scintigraphy in Thyroid Cancer of Advanced, Recurrent,and Metastatic Cases / N.Kasai et al. / p534～534
• General Lecture 663.Lymphography(LG)and Lymphoscintigraphy(LS)in Urogenital Malignancies(Second Report) / Y.Furukawa et al. / p534～534
• General Lecture 664.Estimation of Growth Pattern of Endometrial Carcinoma by Selective Hysterography / S.Inui et al. / p535～535
• General Lecture 665.Endoscopic Local Injection of Adriamycin(ADR)into Canine Gastric Cancer Induced by N-ethy-N'-nitro-N-nitrosoguanidine(ENNG) / T.Ogawa et al. / p535～535
• General Lecture 666.Preoperatively Endoscopic Injection of the MMC-adsorbed Activated Carbon for the Gastric Cancer / T.Ueda et al. / p535～535
• General Lecture 667.A Study on Endoscopic Local Injection (ELI) of Anticancer Agents for Gastric Carcinoma / A.Nashimoto et al. / p536～536
• General Lecture 668.Endoscopic Cryosurgery on Advanced Cancer of Gastro-intestinal Tract / Y.Tsujimoto et al. / p536～536
• General Lecture 669.Slow-releasing Polymer Antitumor Capsule for Treatment of Urological Malignancies / J.Sakatoku et al. / p536～536
• General Lecture 670.Clinical Application of Encapsulated Anti-cancer Drug X. Effect on Renal Cancer as a Preoperative Adjuvant / R.Abe et al. / p537～537
• General Lecture 671.Clinical Application of Microencapsulated Anticancer Drug Ⅺ. Effects on Organ Preserving Operation for Invasive Bladder Carcinoma / K.Sato et al. / p537～537
• General Lecture 672.Intra-arterial Infusion of Micro-encapsulated Mitomycin C in the Treatment of Unresectable Hepatoma(3rd Report) / Y.Tsuji et al. / p537～537
• General Lecture 673.Clinical Studies of Cancer Chemotherapy Combined with Angiotensin-II / N.Takahashi et al. / p538～538
• General Lecture 674.Randomized Controlled Study on Induced Hypertension Chemotherapy / H.Sato et al. / p538～538
• Scientific Exhibition 1.Two Cases of Prolonged Survivor with Multiple Pulmonary Metastases / M.Yamauchi et al. / p539～539
• Scientific Exhibition 2.A Case of Chemotherapeutically Controlled Post-operative Lung Metastasis of Cervical Cancer / T.Kasamatsu et al. / p539～539
• Scientific Exhibition 3.A Case of Metastatic Carcinoma of the Liver with a Primary Lesion in the Colon, Surviving for Three Years and Eight Months after Hepatic Resection (Right Lobe) Done Twice / T.Ohgane et al. / p539～539
• Scientific Exhibition 4.A Five-year Follow-up of the Treatment of Advanced Gastric Carcinoma Associated with Portal Vein Tumor Embolism by the Appleby Operation / H.Koizumi et al. / p540～540
• Scientific Exhibition 5.A Long Survival Case of Esophageal Carcinoma with Repeated Recurrence after Total Esophagectomy / K.Kobayashi et al. / p540～540
• Scientific Exhibition 6.Not Received / /
• Scientific Exhibition 7.Primary Osteogenic of the Skull, Case Report / S.Ito et al. / p540～540
• Scientific Exhibition 8.Clinical Evaluation of Computer Controlled Conformation Radiotherapy / T.Matsuda et al. / p541～541
• Scientific Exhibition 9.Not Received / /

「国立国会図書館デジタルコレクション（雑誌）」より